⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144587 | 0.88 | TAAR1 (0.55) | — | |
| SCHEMBL142886 | 0.86 | TAAR1 (0.53) | — | |
| SCHEMBL141983 | 0.84 | TAAR1 (0.52) | — | |
| SCHEMBL11577289 | 0.84 | TAAR1 (0.52) | — | |
| SCHEMBL9411216 | 0.81 | TAAR1 (0.44) | — | |
| SCHEMBL6075599 | 0.78 | — | — | |
| SCHEMBL11109453 | 0.78 | — | — | |
| SCHEMBL400685 | 0.78 | — | — | |
| SCHEMBL993814 | 0.78 | — | — | |
| SCHEMBL2030841 | 0.78 | TAAR1 (0.71) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 773 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7666866-B2 | Antithrombotic diamides | ELI LILLY AND COMPANY (US) | 2010-02-23 | — | — | US | claimed |
| EP-1819693-B1 | ANTITHROMBOTIC DIAMIDES | LILLY CO ELI (US) | 2009-08-26 | — | — | EP | claimed |
| US-20090062271-A1 | Antithrombotic Diamides | ELI LILLY AND COMPANY (US) | 2009-03-05 | — | — | US | claimed |
| EP-1819693-A1 | ANTITHROMBOTIC DIAMIDES | ELI LILLY AND COMPANY (US) | 2007-08-22 | — | — | EP | claimed |
| WO-2006057868-A1 | ANTITHROMBOTIC DIAMIDES | ELI LILLY AND COMPANY (US) | 2006-06-01 | — | — | WO | claimed |
| EP-0562599-B1 | Condensed thiadiazole derivative, method of its production, and use thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-09-04 | — | — | EP | claimed |
| US-6414003-B1 | ANTIULCER AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-02 | — | — | US | claimed |
| US-5856556-A | Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics | SANKYO COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | claimed |
| US-5574016-A | Peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-12 | — | — | US | claimed |
| US-5512588-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-30 | — | — | US | claimed |
| EP-0417454-A2 | Reduced size LHRH analogs | ABBOTT LABORATORIES (US) | 1991-03-20 | — | — | EP | claimed |
| US-4397784-A | AMINO ACID DERIVATIVE ANTIBIOTICS | ABBOTT LABORATORIES (US) | 1983-08-09 | — | — | US | claimed |
| US-4347355-A | Inhibitors of transpeptidase | ABBOTT LABORATORIES (US) | 1982-08-31 | — | — | US | claimed |
| WO-1982001875-A1 | INHIBITORS OF TRANSPEPTIDASE | ABBOTT LAB (US) | 1982-06-10 | — | — | WO | claimed |
| US-4267340-A | BACTERICIDES; SYNTHESIS OF PENICILLINS AND CEPHALOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-12 | — | — | US | claimed |
| US-4246405-A | Method for preparation of β-lactam compound | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1981-01-20 | — | — | US | claimed |
| US-4092474-A | Cephalosporins having a metaloxy group in 3-substituent | SHIONOGI & CO., LTD. (JA) | 1978-05-30 | — | — | US | claimed |
| US-4009159-A | PENICILLINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-02-22 | — | — | US | claimed |
| US-3993646-A | Process for the ring expansion of penicillins to cephalosporin compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-11-23 | — | — | US | claimed |
| US-20240084308-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2024-03-14 | — | — | US | disclosed |
| US-20240034845-A1 | POLYMER PARTICLES | QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) | 2024-02-01 | — | — | US | disclosed |
| EP-3384549-B1 | SODIUM-ION ELECTROLYTE COMPOSITION | UNIV DEAKIN (AU) | 2024-01-17 | — | — | EP | disclosed |
| US-11834663-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2023-12-05 | — | — | US | disclosed |
| US-20230348674-A1 | HYDROGELS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-11-02 | — | — | US | disclosed |
| WO-2023190111-A1 | RAFT POLYMERIZATION REACTION SOLUTION AND RAFT POLYMERIZATION REACTION SOLUTION PRODUCTION METHOD | テクノＵＭＧ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| CN-113939544-B | non-core-shell polymer particles | 悉尼大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-116615468-A | Polymer particles | 昆士兰科技大学 | 2023-08-18 | — | — | CN | disclosed |
| EP-4225811-A1 | POLYMER PARTICLES | Queensland University Of Technology (AU) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023121483-A1 | IMMUNOSTIMULATORY COMPOSITIONS | VICTORIA LINK LIMITED (NZ) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023102600-A1 | SYNTHESIS OF AMPHIPHILIC BLOCK COPOLYMERS AND POLYMERIC NANOFIBERS PRODUCED THEREFROM | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023099589-A1 | IRAP INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
| EP-4172272-A1 | HYDROGELS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2023-05-03 | — | — | EP | disclosed |
| US-20230091115-A1 | CROSSLINKABLE POLYSILOXANE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-03-23 | — | — | US | disclosed |
| EP-4093807-A1 | CROSSLINKABLE POLYSILOXANE | Commonwealth Scientific and Industrial Research Organisation (AU) | 2022-11-30 | — | — | EP | disclosed |
| CN-115066457-A | Crosslinkable polysiloxanes | 联邦科学和工业研究组织 | 2022-09-16 | — | — | CN | disclosed |
| US-20220177659-A1 | NON-CORE SHELL POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2022-06-09 | — | — | US | disclosed |
| US-20220126270-A1 | CAPTURE OF FLUORINATED CARBON COMPOUNDS | THE UNIVERSITY OF QUEENSLAND (AU) | 2022-04-28 | — | — | US | disclosed |
| EP-3947476-A1 | NON-CORE-SHELL POLYMER PARTICLES | The University of Sydney (AU) | 2022-02-09 | — | — | EP | disclosed |
| CN-113939544-A | Non-core-shell polymer particles | 悉尼大学 | 2022-01-14 | — | — | CN | disclosed |
| WO-2021258147-A1 | HYDROGELS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2021-12-30 | — | — | WO | disclosed |
| EP-3921080-A1 | CAPTURE OF FLUORINATED CARBON COMPOUNDS | The University of Queensland (AU) | 2021-12-15 | — | — | EP | disclosed |
| US-20210340547-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2021-11-04 | — | — | US | disclosed |
| EP-2473486-B2 | PYRIMIDINES AS HEPCIDINE ANTAGONISTS | VIFOR INT AG (CH) | 2021-09-22 | — | — | EP | disclosed |
| US-11078488-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2021-08-03 | — | — | US | disclosed |
| WO-2021146773-A1 | CROSSLINKABLE POLYSILOXANE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2021-07-29 | — | — | WO | disclosed |
| US-10957938-B2 | Sodium-ion electrolyte composition | DEAKIN UNIVERSITY (AU) | 2021-03-23 | — | — | US | disclosed |
| US-20200362354-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2020-11-19 | — | — | US | disclosed |
| WO-2020198789-A1 | NON-CORE-SHELL POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2020-10-08 | — | — | WO | disclosed |
| US-10787668-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2020-09-29 | — | — | US | disclosed |
| WO-2020160626-A1 | CAPTURE OF FLUORINATED CARBON COMPOUNDS | THE UNIVERSITY OF QUEENSLAND (AU) | 2020-08-13 | — | — | WO | disclosed |
| EP-3328384-B1 | FIBROTIC TREATMENT | UNIV MONASH (AU) | 2020-07-29 | — | — | EP | disclosed |
| US-20200093852-A1 | Methods of Treating Ocular Disorders | Beta Therapeutics Pty Ltd (AU) | 2020-03-26 | — | — | US | disclosed |
| EP-3559120-A1 | AQUEOUS POLYMER COMPOSITION | Commonwealth Scientific and Industrial Research Organisation (AU) | 2019-10-30 | — | — | EP | disclosed |
| EP-3554505-A1 | METHODS OF TREATING OCULAR DISORDERS | Beta Therapeutics Pty. Ltd. (AU) | 2019-10-23 | — | — | EP | disclosed |
| US-20190269718-A1 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2019-09-05 | — | — | US | disclosed |
| US-20190249179-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2019-08-15 | — | — | US | disclosed |
| US-20180358654-A1 | SODIUM-ION ELECTROLYTE COMPOSITION | MONASH UNIVERSITY (AU) | 2018-12-13 | — | — | US | disclosed |
| US-20180344763-A1 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-12-06 | — | — | US | disclosed |
| EP-2340271-B1 | POLYMER-BIOACTIVE AGENT CONJUGATES | POLYACTIVA PTY LTD (AU) | 2018-12-05 | — | — | EP | disclosed |
| US-20180327519-A1 | AMPHIPHILIC RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2018-11-15 | — | — | US | disclosed |
| EP-2363419-B1 | Polymer product formed using raft agent | UNIV SYDNEY (AU) | 2018-11-14 | — | — | EP | disclosed |
| US-10100311-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2018-10-16 | — | — | US | disclosed |
| EP-3384549-A1 | SODIUM-ION ELECTROLYTE COMPOSITION | Deakin University (AU) | 2018-10-10 | — | — | EP | disclosed |
| US-10059796-B2 | Conjugated polymers | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-08-28 | — | — | US | disclosed |
| US-20180223287-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2018-08-09 | — | — | US | disclosed |
| US-10029207-B2 | Composite gas separation membrane | THE UNIVERSITY OF MELBOURNE (AU) | 2018-07-24 | — | — | US | disclosed |
| EP-1463765-B1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIV SYDNEY (AU) | 2018-07-18 | — | — | EP | disclosed |
| EP-3004239-B1 | SCRATCH RESISTANT POLYMERS | TENASITECH PTY LTD (AU) | 2018-07-18 | — | — | EP | disclosed |
| EP-3341421-A1 | AMPHIPHILIC RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2018-07-04 | — | — | EP | disclosed |
| WO-2018112555-A1 | AQUEOUS POLYMER COMPOSITION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018107226-A1 | METHODS OF TREATING OCULAR DISORDERS | Beta Therapeutics Pty. Ltd. (AU) | 2018-06-21 | — | — | WO | disclosed |
| EP-2001911-B1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | UNIV SYDNEY (AU) | 2018-06-13 | — | — | EP | disclosed |
| EP-3328384-A1 | FIBROTIC TREATMENT | Monash University (AU) | 2018-06-06 | — | — | EP | disclosed |
| US-20180141912-A1 | VERSATILE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-05-24 | — | — | US | disclosed |
| US-9968684-B2 | Polymer-NSAID conjugate | POLYACTIVA PTY LTD (AU) | 2018-05-15 | — | — | US | disclosed |
| EP-2863921-B1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2018-04-18 | — | — | EP | disclosed |
| EP-3307716-A1 | VERSATILE RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2018-04-18 | — | — | EP | disclosed |
| EP-3265143-A1 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | Commonwealth Scientific & Industrial Research Organisation ( C.S.I.R.O. ) (AU) | 2018-01-10 | — | — | EP | disclosed |
| US-9828351-B2 | Enzyme interacting agents | MONASH UNIVERSITY (AU) | 2017-11-28 | — | — | US | disclosed |
| US-20170333942-A1 | POLYMERISATION PROCESS AND POLYMER PRODUCT | THE UNIVERSITY OF SYDNEY (AU) | 2017-11-23 | — | — | US | disclosed |
| US-20170298026-A1 | ALL PURPOSE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-10-19 | — | — | US | disclosed |
| EP-3204353-A1 | ALL PURPOSE RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-08-16 | — | — | EP | disclosed |
| US-9731321-B2 | Polymerisation process and polymer product | THE UNIVERSITY OF SYDNEY (AU) | 2017-08-15 | — | — | US | disclosed |
| US-20170216765-A1 | COMPOSITE GAS SEPARATION MEMBRANE | THE UNIVERSITY OF MELBOURNE (AU) | 2017-08-03 | — | — | US | disclosed |
| US-9709571-B2 | Method of drug design | VAST BIOSCIENCE PTY LIMITED (AU) | 2017-07-18 | — | — | US | disclosed |
| US-20170190698-A1 | ENZYME INTERACTING AGENTS | CENTRAL ADELAIDE LOCAL HEALTH NETWORK INCORPORATED (AU) | 2017-07-06 | — | — | US | disclosed |
| WO-2017091854-A1 | SODIUM-ION ELECTROLYTE COMPOSITION | DEAKIN UNIVERSITY (AU) | 2017-06-08 | — | — | WO | disclosed |
| US-9663634-B2 | Scratch resistant polymers | TENASITECH PTY LTD (AU) | 2017-05-30 | — | — | US | disclosed |
| US-9650450-B2 | RAFT polymers | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-05-16 | — | — | US | disclosed |
| EP-3160949-A1 | ENZYME INTERACTING AGENTS | Monash University (AU) | 2017-05-03 | — | — | EP | disclosed |
| EP-2791184-B1 | PROCESS FOR REMOVING THIOCARBONYLTHIO GROUPS FROM RAFT POLYMERS | COMMW SCIENT IND RES ORG (AU) | 2017-04-19 | — | — | EP | disclosed |
| US-9617277-B2 | Polymeric materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-04-11 | — | — | US | disclosed |
| EP-2389395-B1 | RAFT POLYMERISATION | COMMW SCIENT IND RES ORG (AU) | 2017-03-29 | — | — | EP | disclosed |
| US-9606440-B2 | Lithographically produced features | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-03-28 | — | — | US | disclosed |
| WO-2017035570-A1 | AMPHIPHILIC RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-03-09 | — | — | WO | disclosed |
| US-9587104-B2 | Release media | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-03-07 | — | — | US | disclosed |
| WO-2017015720-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2017-02-02 | — | — | WO | disclosed |
| EP-3121208-A1 | POLYMERIC MATERIALS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-01-25 | — | — | EP | disclosed |
| WO-2016197187-A1 | VERSATILE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-12-15 | — | — | WO | disclosed |
| EP-2355853-B1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | POLYACTIVA PTY LTD (AU) | 2016-12-07 | — | — | EP | disclosed |
| US-9493419-B2 | Quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2016-11-15 | — | — | US | disclosed |
| US-20160303243-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES LLC (US) | 2016-10-20 | — | — | US | disclosed |
| EP-2507280-B1 | POLYMERIC MATERIALS | COMMW SCIENT IND RES ORG (AU) | 2016-10-19 | — | — | EP | disclosed |
| US-9408919-B2 | Biodegradable polymer—bioactive moiety conjugates | POLYACTIVA PTY LTD. (AU) | 2016-08-09 | — | — | US | disclosed |
| US-20160194439-A1 | CONJUGATED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-07-07 | — | — | US | disclosed |
| US-9346845-B2 | Anionic conjugates of glycosylated bacterial metabolite | GLYCAN BIOSCIENCES LLC (US) | 2016-05-24 | — | — | US | disclosed |
| US-9339781-B2 | Polymer particles | THE UNIVERSITY OF SYDNEY (AU) | 2016-05-17 | — | — | US | disclosed |
| US-9340498-B2 | Raft polymerisation | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESERACH ORGANISATION (AU) | 2016-05-17 | — | — | US | disclosed |
| US-20160122514-A1 | SCRATCH RESISTANT POLYMERS | MILLER WASTE MILLS INC. DBA RTP COMPANY | 2016-05-05 | — | — | US | disclosed |
| US-9321730-B2 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2016-04-26 | — | — | US | disclosed |
| WO-2016054689-A1 | ALL PURPOSE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-04-14 | — | — | WO | disclosed |
| EP-3004239-A1 | SCRATCH RESISTANT POLYMERS | Tenasitech Pty Ltd. (AU) | 2016-04-13 | — | — | EP | disclosed |
| US-9302993-B2 | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2016-04-05 | — | — | US | disclosed |
| EP-2619232-B1 | CONTINUOUS FLOW POLYMERISATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2016-03-16 | — | — | EP | disclosed |
| US-20160052925-A1 | METHOD OF TREATMENT OR PROPHYLAXIS INFTAMMATORY PAIN | NOVARTIS AG (CH) | 2016-02-25 | — | — | US | disclosed |
| US-9255198-B2 | Water swellable polymer materials comprising particulate core and water swellable R.A.F.T polymer shell | THE UNIVERSITY OF SYDNEY (AU) | 2016-02-09 | — | — | US | disclosed |
| US-20160004163-A1 | LITHOGRAPHICALLY PRODUCED FEATURES | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-01-07 | — | — | US | disclosed |
| US-9227968-B2 | Method of treatment or prophylaxis of inflammatory pain | NOVARTIS AG (CH) | 2016-01-05 | — | — | US | disclosed |
| WO-2015196258-A1 | ENZYME INTERACTING AGENTS | MONASH UNIVERSITY (AU) | 2015-12-30 | — | — | WO | disclosed |
| WO-2015192175-A1 | POLYMER HYDROGEL | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-12-23 | — | — | WO | disclosed |
| US-9212257-B2 | Polymeric materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-12-15 | — | — | US | disclosed |
| EP-2952185-A1 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFLAMMATORY PAIN | Spinifex Pharmaceuticals Pty Ltd (AU) | 2015-12-09 | — | — | EP | disclosed |
| US-20150335635-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-11-26 | — | — | US | disclosed |
| US-20150337128-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-11-26 | — | — | US | disclosed |
| EP-2473486-B1 | PYRIMIDINES AS HEPCIDINE ANTAGONISTS | VIFOR INT AG (CH) | 2015-10-28 | — | — | EP | disclosed |
| US-9169211-B2 | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-10-27 | — | — | US | disclosed |
| US-20150150999-A1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2015-06-04 | — | — | US | disclosed |
| WO-2015077836-A1 | SOLAR CONCENTRATOR | THE UNIVERSITY OF MELBOURNE (AU) | 2015-06-04 | — | — | WO | disclosed |
| EP-2863921-A1 | POLYMER-NSAID CONJUGATE | Polyactiva Pty Ltd (AU) | 2015-04-29 | — | — | EP | disclosed |
| US-9018207-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2015-04-28 | — | — | US | disclosed |
| EP-2859088-A1 | RELEASE MEDIA | The University Of Queensland (AU) | 2015-04-15 | — | — | EP | disclosed |
| US-20150094334-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-04-02 | — | — | US | disclosed |
| US-8993697-B2 | Conducting and semiconducting organic materials | Commonwealth Scientific and Industrial Research Institute Organisation (AU) | 2015-03-31 | — | — | US | disclosed |
| US-8975278-B2 | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-03-10 | — | — | US | disclosed |
| WO-2015013747-A1 | CONJUGATED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-02-05 | — | — | WO | disclosed |
| US-8946360-B2 | Continuous flow polymerisation process | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-02-03 | — | — | US | disclosed |
| US-20150024488-A1 | NUCLEIC ACID COMPLEX | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-01-22 | — | — | US | disclosed |
| US-20150025108-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-01-22 | — | — | US | disclosed |
| WO-2014205512-A1 | NOVEL POLYMERS AND THEIR USE IN ORGANIC PHOTOVOLTAICS | THE UNIVERSITY OF MELBOURNE (AU) | 2014-12-31 | — | — | WO | disclosed |
| WO-2014194380-A1 | SCRATCH RESISTANT POLYMERS | TENASITECH PTY LTD (AU) | 2014-12-11 | — | — | WO | disclosed |
| WO-2014190398-A1 | INHIBITION OF AMYLOID FIBRIL FORMATION | THE UNIVERSITY OF MELBOURNE (AU) | 2014-12-04 | — | — | WO | disclosed |
| US-20140350182-A1 | RAFT POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2014-11-27 | — | — | US | disclosed |
| US-20140329932-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2014-11-06 | — | — | US | disclosed |
| US-20140323422-A1 | Anionic Conjugates of Glycosylated Bacterial Metabolite | Glycosynnovations Pty Ltd (AU) | 2014-10-30 | — | — | US | disclosed |
| EP-2791184-A1 | RAFT POLYMERS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2014-10-22 | — | — | EP | disclosed |
| US-8852641-B2 | Polymer microgel beads and preparative method thereof | THE UNIVERSITY OF SYDNEY (AU) | 2014-10-07 | — | — | US | disclosed |
| WO-2014127430-A1 | LITHOGRAPHICALLY PRODUCED FEATURES | THE UNIVERSITY OF QUEENSLAND (AU) | 2014-08-28 | — | — | WO | disclosed |
| US-20140228362-A1 | Method of Treatment or Prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2014-08-14 | — | — | US | disclosed |
| US-20140221455-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | Verva Pharmaceuticals, Inc. (AU) | 2014-08-07 | — | — | US | disclosed |
| US-8796359-B2 | Polymer product and interfacial polymerisation process using raft agent | THE UNIVERSITY OF SYDNEY (AU) | 2014-08-05 | — | — | US | disclosed |
| US-8791245-B2 | Anionic conjugates of glycosylated bacterial metabolite | Glycan Bioscience LLC (US) | 2014-07-29 | — | — | US | disclosed |
| EP-2291175-B1 | ADMINISTRABLE COMPOSITIONS | UNIV SYDNEY (AU) | 2014-07-23 | — | — | EP | disclosed |
| US-8779029-B2 | Polymer product and interfacial polymerisation process using raft agent | THE UNIVERSITY OF SYDNEY (AU) | 2014-07-15 | — | — | US | disclosed |
| WO-2014066936-A9 | SUPRAMOLECULAR STRUCTURE | MONASH UNIVERSITY (AU) | 2014-07-10 | — | — | WO | disclosed |
| US-8765183-B2 | Polymer microgel beads | THE UNIVERSITY OF SYDNEY (AU) | 2014-07-01 | — | — | US | disclosed |
| US-20140142116-A1 | Method of Treatment or Prophylaxis of Inflammatory Pain | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2014-05-22 | — | — | US | disclosed |
| EP-2729182-A1 | NUCLEIC ACID COMPLEX | Commonwealth Scientific and Industrial Research Organisation (AU) | 2014-05-14 | — | — | EP | disclosed |
| US-8722675-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2014-05-13 | — | — | US | disclosed |
| WO-2014066936-A1 | SUPRAMOLECULAR STRUCTURE | MONASH UNIVERSITY (AU) | 2014-05-08 | — | — | WO | disclosed |
| US-20140120058-A1 | POLYMER CONJUGATED PROSTAGLANDIN ANALOGUES | POLYACTIVA PTY LTD | 2014-05-01 | — | — | US | disclosed |
| US-8709486-B2 | Administrable compositions | THE UNIVERSITY OF SYDNEY (AU) | 2014-04-29 | — | — | US | disclosed |
| EP-2044026-B1 | METHOD OF TREATMENT OF GLIOMA BRAIN TUMOUR | PRANA BIOTECHNOLOGY LTD (AU) | 2014-03-26 | — | — | EP | disclosed |
| EP-2696899-A1 | POLYMER CONJUGATED PROSTAGLANDIN ANALOGUES | Polyactiva Pty Ltd (AU) | 2014-02-19 | — | — | EP | disclosed |
| US-20140046018-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | POLYACTIVA PTY LTD. (AU) | 2014-02-13 | — | — | US | disclosed |
| EP-2285881-B1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | UNIV SYDNEY (AU) | 2014-01-22 | — | — | EP | disclosed |
| WO-2014000033-A1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2014-01-03 | — | — | WO | disclosed |
| WO-2013181713-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-12-12 | — | — | WO | disclosed |
| EP-1755373-B2 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2013-11-27 | — | — | EP | disclosed |
| US-20130296350-A1 | Method of Treatment or Prophylaxis | NOVARTIS AG (CH) | 2013-11-07 | — | — | US | disclosed |
| US-20130289217-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-10-31 | — | — | US | disclosed |
| EP-2650010-A1 | Method of treatment or prophylaxis | Spinifex Pharmaceuticals Pty Ltd (AU) | 2013-10-16 | — | — | EP | disclosed |
| EP-2650011-A1 | Method of treatment or prophylaxis | Spinifex Pharmaceuticals Pty Ltd (AU) | 2013-10-16 | — | — | EP | disclosed |
| US-8557737-B2 | Methods of altering poppy characteristics | GlaxoSmithKline Australia, Pty, Ltd (AU) | 2013-10-15 | — | — | US | disclosed |
| US-8551950-B2 | Method of treatment or prophylaxis of inflammatory pain | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2013-10-08 | — | — | US | disclosed |
| US-8535655-B2 | Biodegradable polymer—bioactive moiety conjugates | POLYACTIVA PTY LTD. (AU) | 2013-09-17 | — | — | US | disclosed |
| US-20130217841-A1 | CONTINUOUS FLOW POLYMERISATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-08-22 | — | — | US | disclosed |
| US-20130217726-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | ST. VINCENT'S INSTITUTE OF MEDICAL RESEARCH (AU) | 2013-08-22 | — | — | US | disclosed |
| US-8501889-B2 | Conducting and semiconducting organic materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-08-06 | — | — | US | disclosed |
| EP-2619232-A1 | CONTINUOUS FLOW POLYMERISATION PROCESS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2013-07-31 | — | — | EP | disclosed |
| US-8492382-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2013-07-23 | — | — | US | disclosed |
| US-20130172210-A1 | METHOD OF DRUG DESIGN | ALCHEMIA LIMITED (AU) | 2013-07-04 | — | — | US | disclosed |
| WO-2013086585-A1 | RAFT POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-06-20 | — | — | WO | disclosed |
| US-20130136848-A1 | POLYMERISATION PROCESS AND POLYMER PRODUCT | THE UNIVERSITY OF SYDNEY (AU) | 2013-05-30 | — | — | US | disclosed |
| EP-1830869-B1 | METHOD OF TREATMENT OR PROPHYLAXIS | SPINIFEX PHARM PTY LTD (AU) | 2013-05-22 | — | — | EP | disclosed |
| US-8426345-B2 | Method of drug design | ALCHEMIA LIMITED (AU) | 2013-04-23 | — | — | US | disclosed |
| US-20130087736-A1 | WATER SWELLABLE POLYMER MATERIALS | THE UNIVERSITY OF SYDNEY (AU) | 2013-04-11 | — | — | US | disclosed |
| US-8404686-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2013-03-26 | — | — | US | disclosed |
| US-20130068294-A1 | DYE-SENSITISED SOLAR CELL WITH NICKEL CATHODE | Commwealth Scientific and Industrial Reseach Organisation | 2013-03-21 | — | — | US | disclosed |
| EP-2285882-B1 | POLYMER MICROGEL BEADS | UNIV SYDNEY (AU) | 2013-03-20 | — | — | EP | disclosed |
| US-8377963-B2 | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof | HOWARD FLOREY INSTITUTE (AU) | 2013-02-19 | — | — | US | disclosed |
| US-8377851-B2 | Method of altering the alkaloid composition in poppy plants | GLAXOSMITHKLINE AUSTRALIA PTY. LTD. (AU) | 2013-02-19 | — | — | US | disclosed |
| EP-2553518-A1 | DYE-SENSITISED SOLAR CELL WITH NICKEL CATHODE | The University Of Melbourne (AU) | 2013-02-06 | — | — | EP | disclosed |
| EP-1802662-B1 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | UNIV SYDNEY (AU) | 2013-01-23 | — | — | EP | disclosed |
| EP-2545923-A1 | Antibacterial agents | Alchemia Limited (AU) | 2013-01-16 | — | — | EP | disclosed |
| WO-2013003887-A1 | NUCLEIC ACID COMPLEX | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-01-10 | — | — | WO | disclosed |
| US-20120309787-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | ST. VINCENT'S INSTITUTE OF MEDICAL RESEARCH (AU) | 2012-12-06 | — | — | US | disclosed |
| WO-2012162742-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2012-12-06 | — | — | WO | disclosed |
| EP-1934388-B1 | METHOD OF DRUG DESIGN | ALCHEMIA LTD (AU) | 2012-12-05 | — | — | EP | disclosed |
| EP-1789079-B1 | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof | FLOREY HOWARD INST (AU) | 2012-11-07 | — | — | EP | disclosed |
| WO-2012142670-A1 | NUCLEAR MAGNETIC RESONANCE AGENT | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-10-26 | — | — | WO | disclosed |
| US-8293812-B2 | Containing thermoplastic resin having solid particles dispersed throughout; controlling particle size; modulus; high tensile strength | The University of Queensland St. Lucia (AU) | 2012-10-23 | — | — | US | disclosed |
| WO-2012139164-A1 | POLYMER CONJUGATED PROSTAGLANDIN ANALOGUES | POLYACTIVA PTY LTD (AU) | 2012-10-18 | — | — | WO | disclosed |
| EP-2507280-A1 | POLYMERIC MATERIALS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2012-10-10 | — | — | EP | disclosed |
| EP-2507322-A1 | WATER SWELLABLE POLYMER MATERIALS | The University Of Sydney (AU) | 2012-10-10 | — | — | EP | disclosed |
| US-20120252967-A1 | POLYURETHANES | GRAINS RESEARCH AND DEVELOPMENT CORPORATION (AU) | 2012-10-04 | — | — | US | disclosed |
| US-8273403-B2 | Generation of surface coating diversity | BIO-LAYER PTY LTD. (AU) | 2012-09-25 | — | — | US | disclosed |
| US-20120238706-A1 | POLYMERIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-09-20 | — | — | US | disclosed |
| US-8263775-B2 | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof | HOWARD FLOREY INSTITUTE (AU) | 2012-09-11 | — | — | US | disclosed |
| EP-2069830-B1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | CARL ZEISS VISION AU HOLDING (AU) | 2012-08-29 | — | — | EP | disclosed |
| US-20120214798-A1 | Novel Ethanediamone Hepcidine Antagonists | VIFOR (INTERNATIONAL) AG (CH) | 2012-08-23 | — | — | US | disclosed |
| US-20120202877-A1 | ANTI-INFLUENZA AGENTS | GRIFFITH UNIVERSITY (AU) | 2012-08-09 | — | — | US | disclosed |
| US-20120202806-A1 | Novel Pyrimidine- And Triazine-Hepcidine Antagonists | VIFOR (INTERNATIONAL) AG (CH) | 2012-08-09 | — | — | US | disclosed |
| EP-2475643-A1 | NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2012-07-18 | — | — | EP | disclosed |
| EP-2473486-A1 | NOVEL PYRIMIDINE AND TRIAZINE HEPCIDINE ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2012-07-11 | — | — | EP | disclosed |
| WO-2012083866-A1 | QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2012-06-28 | — | — | WO | disclosed |
| US-20120165370-A1 | QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2012-06-28 | — | — | US | disclosed |
| US-20120128743-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2012-05-24 | — | — | US | disclosed |
| EP-2454248-A1 | ANTI -INFLUENZA AGENTS | Griffith University (AU) | 2012-05-23 | — | — | EP | disclosed |
| US-8163760-B2 | Use of pyridopyrimidine compounds in the treatment of gliomas | PRANA BIOTECHNOLOGY LIMITED (AU) | 2012-04-24 | — | — | US | disclosed |
| WO-2012037596-A1 | CONTINUOUS FLOW POLYMERISATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-03-29 | — | — | WO | disclosed |
| US-20120059047-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | VERVA PHARMACEUTICALS PTY LTD (AU) | 2012-03-08 | — | — | US | disclosed |
| EP-2421877-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | Glycan Biosciences Pty Ltd (AU) | 2012-02-29 | — | — | EP | disclosed |
| US-8106108-B2 | Ultraviolet light absorbing optical elements and compositions and methods for manufacture | CARL ZEISS VISION AUSTRALIA HOLDINGS LIMITED (AU) | 2012-01-31 | — | — | US | disclosed |
| US-8093227-B2 | Monosaccharide compounds and methods therefor | ALCHEMIA PTY LTD (AU) | 2012-01-10 | — | — | US | disclosed |
| US-20120004381-A1 | RAFT POLYMERISATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-01-05 | — | — | US | disclosed |
| US-20120004259-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | SPINIFEX PHARMACEUTICALS, PTY LTD (AU) | 2012-01-05 | — | — | US | disclosed |
| EP-2401304-A1 | POLYMER PARTICLES | The University Of Sydney (AU) | 2012-01-04 | — | — | EP | disclosed |
| US-20110318329-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | NOVARTIS AG (CH) | 2011-12-29 | — | — | US | disclosed |
| EP-2389395-A1 | RAFT POLYMERISATION | Commonwealth Scientific and Industrial Research Organisation (AU) | 2011-11-30 | — | — | EP | disclosed |
| US-20110256644-A1 | MASKS FOR MICROLITHOGRAPHY AND METHODS OF MAKING AND USING SUCH MASKS | MICRON TECHNOLOGY, INC. (US) | 2011-10-20 | — | — | US | disclosed |
| EP-1534755-B1 | GENERATION OF SURFACE COATING DIVERSITY | BIO LAYER PTY LTD (AU) | 2011-10-12 | — | — | EP | disclosed |
| WO-2011120103-A1 | DYE-SENSITISED SOLAR CELL WITH NICKEL CATHODE | THE UNIVERSITY OF MELBOURNE (AU) | 2011-10-06 | — | — | WO | disclosed |
| US-20110243884-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | THE BIONICS INSTITUTE OF AUSTRALIA (AU) | 2011-10-06 | — | — | US | disclosed |
| EP-2363419-A1 | Polymer product formed using raft agent | The University of Sydney (AU) | 2011-09-07 | — | — | EP | disclosed |
| EP-2355853-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | The Bionic Ear Institute (AU) | 2011-08-17 | — | — | EP | disclosed |
| US-20110196088-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2011-08-11 | — | — | US | disclosed |
| US-20110190233-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES PTY LTD (AU) | 2011-08-04 | — | — | US | disclosed |
| US-20110190566-A1 | POLYMER MICROGEL BEADS | UNIVERSITY OF SYDNEY (AU) | 2011-08-04 | — | — | US | disclosed |
| US-7989422-B2 | Antibacterial agents | ALCHEMIA LIMITED (AU) | 2011-08-02 | — | — | US | disclosed |
| US-20110166298-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL ORGANISATION (AU) | 2011-07-07 | — | — | US | disclosed |
| EP-2340271-A1 | POLYMER-BIOACTIVE AGENT CONJUGATES | The Bionic Ear Institute (AU) | 2011-07-06 | — | — | EP | disclosed |
| US-20110136988-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | Commonwealth Scientific an dIndustrial Research Organisation (AU) | 2011-06-09 | — | — | US | disclosed |
| WO-2011066608-A1 | WATER SWELLABLE POLYMER MATERIALS | THE UNIVERSITY OF SYDNEY (AU) | 2011-06-09 | — | — | WO | disclosed |
| WO-2011066616-A1 | POLYMERIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-06-09 | — | — | WO | disclosed |
| US-20110129417-A1 | ADMINISTRABLE COMPOSITIONS | UNIVERSITY OF SYDNEY (AU) | 2011-06-02 | — | — | US | disclosed |
| US-20110118533-A1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | UNIVERSITY OF SYDNEY (AU) | 2011-05-19 | — | — | US | disclosed |
| WO-2011029832-A1 | NOVEL THIAZOL AND OXAZOL HEPCIDINE ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011026959-A1 | NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011026835-A1 | NOVEL PYRIMIDINE AND TRIAZINE HEPCIDINE ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2011-03-10 | — | — | WO | disclosed |
| EP-2291175-A1 | ADMINISTRABLE COMPOSITIONS | THE UNIVERSITY OF SYDNEY (AU) | 2011-03-09 | — | — | EP | disclosed |
| WO-2011023722-A1 | NOVEL QUINOXALINONE HEPCIDIN ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2011-03-03 | — | — | WO | disclosed |
| EP-2285881-A1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | THE UNIVERSITY OF SYDNEY (AU) | 2011-02-23 | — | — | EP | disclosed |
| EP-2285882-A1 | POLYMER MICROGEL BEADS | THE UNIVERSITY OF SYDNEY (AU) | 2011-02-23 | — | — | EP | disclosed |
| US-20110021563-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE (AU) | 2011-01-27 | — | — | US | disclosed |
| WO-2011006208-A1 | ANTI -INFLUENZA AGENTS | GRIFFITH UNIVERSITY (AU) | 2011-01-20 | — | — | WO | disclosed |
| EP-2265661-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | Commonwealth Scientific and Industrial Research Organisation (AU) | 2010-12-29 | — | — | EP | disclosed |
| EP-2265654-A1 | POLYURETHANES | Commonwealth Scientific and Industrial Research Organisation (AU) | 2010-12-29 | — | — | EP | disclosed |
| EP-2262797-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | Howard Florey Institute (AU) | 2010-12-22 | — | — | EP | disclosed |
| US-20100292159-A1 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFLAMMATORY PAIN | UNIVERSITY OF QUEENSLAND (AU) | 2010-11-18 | — | — | US | disclosed |
| US-7828840-B2 | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists | MED INSTITUTE, INC. (US) | 2010-11-09 | — | — | US | disclosed |
| EP-1916889-B1 | METHODS OF ALTERING POPPY CHARACTERISTICS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2010-11-03 | — | — | EP | disclosed |
| WO-2010118471-A1 | REACTOR AND METHOD FOR PERFORMING A CHEMICAL REACTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-10-21 | — | — | WO | disclosed |
| US-20100240886-A1 | PROCESS FOR PRODUCING CARBAPENEM COMPOUND | KANEKA CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| US-7795275-B2 | Method of treatment or prophylaxis | UNIQUEST PTY LIMITED (AU) | 2010-09-14 | — | — | US | disclosed |
| US-20100227975-A1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIVERSITY OF SYDNEY (AU) | 2010-09-09 | — | — | US | disclosed |
| WO-2010096867-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010091465-A1 | POLYMER PARTICLES | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010083569-A1 | RAFT POLYMERISATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2010-07-29 | — | — | WO | disclosed |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | ALCHEMIA PTY LTD. (AU) | 2010-07-22 | — | — | US | disclosed |
| US-7745553-B2 | Aqueous dispersions of polymer particles | UNIVERSITY OF SYDNEY (AU) | 2010-06-29 | — | — | US | disclosed |
| WO-2010040188-A9 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | THE BIONIC EAR INSTITUTE (AU) | 2010-06-17 | — | — | WO | disclosed |
| US-20100104546-A1 | MODULATORS OF ANTIGEN-DEPENDENT T CELL PROLIFERATION | CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE (AU) | 2010-04-29 | — | — | US | disclosed |
| WO-2010040188-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | THE BIONIC EAR INSTITUTE (AU) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010040187-A1 | POLYMER-BIOACTIVE AGENT CONJUGATES | THE BIONIC EAR INSTITUTE (AU) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010037179-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES PTY LTD (AU) | 2010-04-08 | — | — | WO | disclosed |
| EP-2172491-A1 | Polymer obtained by the use of RAFT-agents and process of encapsulating of particulate material by said polymer. | The University of Sydney (AU) | 2010-04-07 | — | — | EP | disclosed |
| EP-1755373-B1 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2010-03-24 | — | — | EP | disclosed |
| US-20100069393-A1 | METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME | PRANA BIOTECHNOLOGY LIMITED (AU) | 2010-03-18 | — | — | US | disclosed |
| WO-2010020008-A1 | POLYMER COATINGS | POLYMERS CRC LIMITED (AU) | 2010-02-25 | — | — | WO | disclosed |
| US-20100048750-A1 | VESICULATED POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2010-02-25 | — | — | US | disclosed |
| US-7666866-B2 | Antithrombotic diamides | ELI LILLY AND COMPANY (US) | 2010-02-23 | — | — | US | disclosed |
| US-20100041787-A1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | CARL ZEISS VISION AUSTRALIA HOLDINGS LIMITED (AU) | 2010-02-18 | — | — | US | disclosed |
| WO-2009155657-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-12-30 | — | — | WO | disclosed |
| WO-2009149496-A1 | TREATMENT OF DIABETES AND COMPLICATIONS THEREOF AND RELATED DISORDERS | CENTRAL NORTHERN ADELAIDE HEALTH SERVICE (AU) | 2009-12-17 | — | — | WO | disclosed |
| EP-2120916-A1 | MODULATORS OF ANTIGEN-DEPENDENT T CELL PROLIFERATION | Children, Youth and Womens's Health Service Incorporated (AU) | 2009-11-25 | — | — | EP | disclosed |
| WO-2009137890-A1 | ADMINISTRABLE COMPOSITIONS | THE UNIVERSITY OF SYDNEY (AU) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009137889-A1 | POLYMER MICROGEL BEADS | THE UNIVERSITY OF SYDNEY (AU) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009137888-A1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | THE UNIVERSITY OF SYDNEY (AU) | 2009-11-19 | — | — | WO | disclosed |
| US-7619091-B2 | Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052) | PRANA BIOTECHNOLOGY LIMITED (AU) | 2009-11-17 | — | — | US | disclosed |
| WO-2009127012-A1 | POLYURETHANES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009127009-A1 | CONDENSATION POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009127011-A1 | MODIFIED CONDENSATION POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009127010-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| US-20090258979-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2009-10-15 | — | — | US | disclosed |
| WO-2009111830-A1 | CONJUGATED UNSATURATED COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-09-17 | — | — | WO | disclosed |
| EP-1838714-A4 | METHODS OF TREATING PAIN | UNIV QUEENSLAND (AU) | 2009-09-02 | — | — | EP | disclosed |
| EP-1539700-B1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LTD (AU) | 2009-08-26 | — | — | EP | disclosed |
| EP-1819693-B1 | ANTITHROMBOTIC DIAMIDES | LILLY CO ELI (US) | 2009-08-26 | — | — | EP | disclosed |
| EP-1802662-A4 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | UNIV SYDNEY (AU) | 2009-08-26 | — | — | EP | disclosed |
| US-20090177267-A1 | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2009-07-09 | — | — | US | disclosed |
| US-7557118-B2 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2009-07-07 | — | — | US | disclosed |
| US-20090163373-A1 | Method of Drug Design | ALCHEMIA LIMITED (AU) | 2009-06-25 | — | — | US | disclosed |
| EP-2069830-A1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | Carl Zeiss Vision Australia Holdings Ltd. (AU) | 2009-06-17 | — | — | EP | disclosed |
| US-20090143417-A1 | METHODS OF TREATING PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2009-06-04 | — | — | US | disclosed |
| WO-2009065169-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE (AU) | 2009-05-28 | — | — | WO | disclosed |
| EP-2059496-A1 | ACETYLENIC COMPOUNDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2009-05-20 | — | — | EP | disclosed |
| EP-2044026-A1 | METHOD OF TREATMENT OF GLIOMA BRAIN TUMOUR | Prana Biotechnology Limited (AU) | 2009-04-08 | — | — | EP | disclosed |
| US-20090075822-A1 | Method of Altering the Alkaloid Composition in Poppy Plants | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2009-03-19 | — | — | US | disclosed |
| EP-1916889-A4 | METHODS OF ALTERING POPPY CHARACTERISTICS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2009-03-11 | — | — | EP | disclosed |
| US-20090062271-A1 | Antithrombotic Diamides | ELI LILLY AND COMPANY (US) | 2009-03-05 | — | — | US | disclosed |
| WO-2009024095-A1 | METHOD OF MAKING AND ADMINISTERING QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2009-02-26 | — | — | WO | disclosed |
| US-20090054482-A1 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2009-02-26 | — | — | US | disclosed |
| US-20090023669-A1 | Antibacterial Agents | ALCHEMIA LIMITED (AU) | 2009-01-22 | — | — | US | disclosed |
| WO-2009006668-A1 | MODULATORS OF ANTIGEN-DEPENDENT T CELL PROLIFERATION | CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE (AU) | 2009-01-15 | — | — | WO | disclosed |
| WO-2009009554-A1 | AZO COLOURANT | HUNTSMAN CORPORATION AUSTRALIA PTY LIMITED (AU) | 2009-01-15 | — | — | WO | disclosed |
| EP-1149075-B1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS | COMMW SCIENT IND RES ORG (AU) | 2008-12-31 | — | — | EP | disclosed |
| WO-2009000049-A1 | INTRINSICALLY CONDUCTING POLYMERS | CRC SMARTPRINT PTY LTD (AU) | 2008-12-31 | — | — | WO | disclosed |
| EP-2006290-A1 | IMPROVED PROCESS FOR PRODUCING CARBAPENEM COMPOUND | Kaneka Corporation (JP) | 2008-12-24 | — | — | EP | disclosed |
| EP-2001911-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | The University of Sydney (AU) | 2008-12-17 | — | — | EP | disclosed |
| WO-2008144822-A1 | HOLOGRAPHIC RECORDING MEDIUM | ADVANCED POLYMERIK PTY LTD (AU) | 2008-12-04 | — | — | WO | disclosed |
| EP-1996183-A1 | METHOD OF TREATMENT OR PROPHYLAXIS INFLAMMATORY PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-12-03 | — | — | EP | disclosed |
| US-20080281016-A1 | Polymer Composite | MILLER WASTE MILLS INC. DBA RTP COMPANY | 2008-11-13 | — | — | US | disclosed |
| US-20080269058-A1 | Methods of Altering Poppy Characteristics | SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (AU) | 2008-10-30 | — | — | US | disclosed |
| US-20080268250-A1 | Polymerisation Process and Polymer Product | THE UNIVERSITY OF SYDNEY (AU) | 2008-10-30 | — | — | US | disclosed |
| EP-1962864-A1 | ANTIBACTERIAL AGENTS | Alchemia Limited (AU) | 2008-09-03 | — | — | EP | disclosed |
| US-7417129-B2 | Combinatorial libraries of monosaccharides | ALCHEMIA PTY LTD (AU) | 2008-08-26 | — | — | US | disclosed |
| US-20080194636-A1 | Enzyme Inhibitors and Uses Thereof | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2008-08-14 | — | — | US | disclosed |
| US-20080161353-A1 | 8-Hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2008-07-03 | — | — | US | disclosed |
| EP-1934388-A1 | METHOD OF DRUG DESIGN | Alchemia Ltd (AU) | 2008-06-25 | — | — | EP | disclosed |
| US-7371755-B1 | Antiviral agents | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) | 2008-05-13 | — | — | US | disclosed |
| EP-1755373-A4 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2008-05-07 | — | — | EP | disclosed |
| EP-1916889-A1 | METHODS OF ALTERING POPPY CHARACTERISTICS | Glaxosmithkline Australia PTY Ltd. (AU) | 2008-05-07 | — | — | EP | disclosed |
| WO-2008046155-A1 | METHODS FOR REGULATING GLUCOSE HOMEOSTASIS AND AGENTS THEREFOR | DIA-B TECH LIMITED (AU) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008046156-A1 | VESICULATED POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2008-04-24 | — | — | WO | disclosed |
| EP-1366015-A4 | BENZENE-1 2-DIOL MANNICH BASES LIGANDS POLYMERS AND METHOD OF SELECTIVE METAL IONS REMOVAL | TECH RESOURCES PTY LTD (AU) | 2008-03-26 | — | — | EP | disclosed |
| WO-2008031157-A1 | ACETYLENIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2008-03-20 | — | — | WO | disclosed |
| WO-2008028217-A1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | CARL ZEISS VISION AUSTRALIA HOLDINGS LIMITED (AU) | 2008-03-13 | — | — | WO | disclosed |
| US-20080009418-A1 | Selective Inhibitors | ALCHEMIA LTD. (AU) | 2008-01-10 | — | — | US | disclosed |
| WO-2007147217-A1 | METHOD OF TREATMENT OF GLIOMA BRAIN TUMOUR | PRANA BIOTECHNOLOGY LIMITED (AU) | 2007-12-27 | — | — | WO | disclosed |
| EP-1326873-A4 | COMBINATORIAL LIBRARIES OF MONOSACCHARIDES | ALCHEMIA PTY LTD (AU) | 2007-12-19 | — | — | EP | disclosed |
| WO-2007112503-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2007-10-11 | — | — | WO | disclosed |
| EP-1838714-A1 | METHODS OF TREATING PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-10-03 | — | — | EP | disclosed |
| WO-2007106938-A1 | METHOD OF TREATMENT OR PROPHYLAXIS INFLAMMATORY PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-09-27 | — | — | WO | disclosed |
| EP-1830869-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-09-12 | — | — | EP | disclosed |
| WO-2007095696-A1 | POLYKETIDE XANTHONES AND USES THEREOF | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-08-30 | — | — | WO | disclosed |
| EP-1819693-A1 | ANTITHROMBOTIC DIAMIDES | ELI LILLY AND COMPANY (US) | 2007-08-22 | — | — | EP | disclosed |
| EP-1802662-A1 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | The University of Sydney (AU) | 2007-07-04 | — | — | EP | disclosed |
| WO-2007070947-A1 | ANTIBACTERIAL AGENTS | ALCHEMIA LTD (AU) | 2007-06-28 | — | — | WO | disclosed |
| EP-1797428-A1 | SELECTIVE INHIBITORS | Alchemia Pty Ltd (AU) | 2007-06-20 | — | — | EP | disclosed |
| EP-1789079-A1 | ENZYME INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2007-05-30 | — | — | EP | disclosed |
| EP-1334092-B1 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | UNIV MONASH (AU) | 2007-05-09 | — | — | EP | disclosed |
| WO-2007038829-A1 | METHOD OF DRUG DESIGN | ALCHEMIA LTD (AU) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007033409-A1 | PHOTOELECTRIC MATERIALS AND PHOTOVOLTAIC CELLS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2007-03-29 | — | — | WO | disclosed |
| EP-1483253-A4 | AN ANTIMICROBIAL AGENT | UNIV GRIFFITH (AU) | 2007-03-21 | — | — | EP | disclosed |
| WO-2007022561-A1 | METHODS OF ALTERING POPPY CHARACTERISTICS | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2007-03-01 | — | — | WO | disclosed |
| EP-1755373-A1 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | Glaxosmithkline Australia PTY Ltd. (AU) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006122344-A1 | POLYMERISATION AGENT | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2006-11-23 | — | — | WO | disclosed |
| US-7122694-B2 | Hydroboronation process | BORON MOLECULAR PTY LIMITED (AU) | 2006-10-17 | — | — | US | disclosed |
| US-7122673-B2 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2006-10-17 | — | — | US | disclosed |
| US-7122699-B2 | Process for preparing organic boronic acid derivatives using diboronic acid | BORON MOLECULAR LIMITED (AU) | 2006-10-17 | — | — | US | disclosed |
| US-20060223936-A1 | Polymerization of a dispersion having a continuous aqueous phase and a dispersed organic phase of an unsaturated monomer(s), and an amphiphilic RAFT agent, which is an addition polymer residue capped with a compound containing a dithio ester or a trithiocarbonate group; paint, filler, adhesive, seals | UNIVERSITY OF SYDNEY (AU) | 2006-10-05 | — | — | US | disclosed |
| US-20060223741-A1 | Method of treatment or prophylaxis | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-10-05 | — | — | US | disclosed |
| WO-2006066361-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006066362-A1 | METHODS OF TREATING PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-06-29 | — | — | WO | disclosed |
| EP-1539700-A4 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LTD (AU) | 2006-06-28 | — | — | EP | disclosed |
| EP-1664071-A1 | NOVEL SULFENAMIDE OXIDES | GRIFFITH UNIVERSITY (AU) | 2006-06-07 | — | — | EP | disclosed |
| EP-1664072-A1 | NOVEL SULFENAMIDES | GRIFFITH UNIVERSITY (AU) | 2006-06-07 | — | — | EP | disclosed |
| WO-2006057868-A1 | ANTITHROMBOTIC DIAMIDES | ELI LILLY AND COMPANY (US) | 2006-06-01 | — | — | WO | disclosed |
| EP-1463765-A4 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIV SYDNEY (AU) | 2006-05-10 | — | — | EP | disclosed |
| US-20060089380-A1 | 8-Hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LTD. (AU) | 2006-04-27 | — | — | US | disclosed |
| US-20060083858-A1 | Generation of surface coating diversity | ANTEO TECHNOLOGIES PTY LTD (AU) | 2006-04-20 | — | — | US | disclosed |
| WO-2006037161-A1 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006037159-A1 | SELECTIVE INHIBITORS | ALCHEMIA LIMITED (AU) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006037185-A1 | NOVEL SULFENAMIDES AND SULFENAMIDE OXIDES | GRIFFITH UNIVERSITY (AU) | 2006-04-13 | — | — | WO | disclosed |
| US-7019000-B1 | Method of treating a disease condition caused or exacerbated by an HPV | INSTITUTE OF MOLECULAR & CELL BIOLOGY (SG) | 2006-03-28 | — | — | US | disclosed |
| WO-2006026832-A1 | ENZYME INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2006-03-16 | — | — | WO | disclosed |
| US-7012142-B2 | Process for preparation of bicyclic and polycyclic molecules | MONASH UNIVERSITY (AU) | 2006-03-14 | — | — | US | disclosed |
| WO-2006024068-A1 | POLYMER COMPOSITE | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-03-09 | — | — | WO | disclosed |
| EP-1621533-A1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2006-02-01 | — | — | EP | disclosed |
| US-20060014702-A1 | Antimicrobial agent | GRIFFITH UNIVERSITY (AU) | 2006-01-19 | — | — | US | disclosed |
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | VERVA PHARMACEUTICALS PTY LTD (AU) | 2005-12-22 | — | — | US | disclosed |
| EP-0993463-B1 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | BORON MOLECULAR PTY LTD (AU) | 2005-11-30 | — | — | EP | disclosed |
| US-6967197-B2 | Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-11-22 | — | — | US | disclosed |
| WO-2005107436-A1 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2005-11-17 | — | — | WO | disclosed |
| EP-0981517-B1 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES | UNIV AUSTRALIAN (AU) | 2005-11-16 | — | — | EP | disclosed |
| EP-1112250-A4 | THERAPEUTIC COMPOUNDS AND METHODS | INST OF MOLECUL & CELL BIOLOGY (SG) | 2005-09-14 | — | — | EP | disclosed |
| US-6939985-B1 | covalently coupling organic compounds by reacting an aromatic ring compound having a halogen or halogen-like substituent at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a base | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2005-09-06 | — | — | US | disclosed |
| EP-1534755-A4 | GENERATION OF SURFACE COATING DIVERSITY | BIO LAYER PTY LTD (AU) | 2005-08-17 | — | — | EP | disclosed |
| WO-2005065686-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | ADIPOGEN PHARMACEUTICALS PTY LIMITED (AU) | 2005-07-21 | — | — | WO | disclosed |
| US-20050154004-A1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | AUSTRALIAN NATIONAL UNIVERSITY, THE (AU) | 2005-07-14 | — | — | US | disclosed |
| US-6911469-B2 | Sulfonamide compounds and pharmaceutical use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-06-28 | — | — | US | disclosed |
| EP-1539700-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | Prana Biotechnology Ltd (AU) | 2005-06-15 | — | — | EP | disclosed |
| US-20050124559-A1 | Antimicrobial agent | UNIVERSITY, MONASH (AU) | 2005-06-09 | — | — | US | disclosed |
| EP-1121365-B1 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2005-06-08 | — | — | EP | disclosed |
| EP-1019414-B1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMW SCIENT IND RES ORG (AU) | 2005-06-08 | — | — | EP | disclosed |
| US-20050119461-A1 | Novel receptor, and compounds which bind thereto | THE UNIVERSITY OF MELBOURNE | 2005-06-02 | — | — | US | disclosed |
| EP-1534755-A1 | GENERATION OF SURFACE COATING DIVERSITY | Bio-Layer Pty Limited (AU) | 2005-06-01 | — | — | EP | disclosed |
| US-6890934-B2 | Sulfonamide compounds and uses thereof as medicines | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-10 | — | — | US | disclosed |
| WO-2005019237-A1 | NOVEL SULFENAMIDES | GRIFFITH UNIVERSITY (AU) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005019236-A1 | NOVEL SULFENAMIDE OXIDES | GRIFFITH UNIVERSITY (AU) | 2005-03-03 | — | — | WO | disclosed |
| EP-1506213-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2005-02-16 | — | — | EP | disclosed |
| EP-1000108-B1 | AQUEOUS POLYIMIDE PROCESS | COMMW SCIENT IND RES ORG (AU) | 2005-01-05 | — | — | EP | disclosed |
| EP-1127060-B8 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2005-01-05 | — | — | EP | disclosed |
| EP-1483253-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2004-12-08 | — | — | EP | disclosed |
| WO-2004096766-A1 | A METHOD OF INDOLE SYNTHESIS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2004-11-11 | — | — | WO | disclosed |
| EP-1463765-A1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | University of Sydney (AU) | 2004-10-06 | — | — | EP | disclosed |
| US-6794529-B2 | CATALYTIC REACTION OF DIBORANE COMPOUND USING GROUP 8 METAL CATALYST | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-09-21 | — | — | US | disclosed |
| US-20040180947-A1 | hypoglycemic activity or phoshodiesterase-V inhibitory activity; prophylaxis and treatment of impaired glucose tolerance disorder, diabetes (e.g., type II diabetes), diabetic complications | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-09-16 | — | — | US | disclosed |
| EP-1334092-A4 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | UNIV MONASH (AU) | 2004-08-11 | — | — | EP | disclosed |
| WO-2004065334-A1 | METHOD OF REMOVING ORGANOTIN RESIDUE | CHIROGEN PTY LIMITED (AU) | 2004-08-05 | — | — | WO | disclosed |
| WO-2004065335-A1 | ENANTIOSELECTIVE REDUCTION METHOD | CHIROGEN PTY LIMITED (AU) | 2004-08-05 | — | — | WO | disclosed |
| US-20040138488-A1 | Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal | TECHNOLOGICAL RESOURCES PTY LTD. (AU) | 2004-07-15 | — | — | US | disclosed |
| US-20040133028-A1 | Hydroboronation process | COMMONWEALTH SCIENTIFIC | 2004-07-08 | — | — | US | disclosed |
| US-20040110727-A1 | Aldehyde-releasing compounds | LA TROBE UNIVERSITY (AU) | 2004-06-10 | — | — | US | disclosed |
| WO-2004031198-A1 | ENANTIOSELECTIVE REDUCTIVE METHODS USING CHIRAL ORGANOSTANNANES | CHIROGEN PTY LIMITED (AU) | 2004-04-15 | — | — | WO | disclosed |
| EP-1127060-B1 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2004-04-07 | — | — | EP | disclosed |
| US-6713566-B1 | CATALYTIC HYDROBORATION OF OLEFINIC OR ACETYLENIC FUNCTIONA-LIZED MATERIAL UNDER MILD CONDITIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-03-30 | — | — | US | disclosed |
| EP-1140895-B1 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-03-24 | — | — | EP | disclosed |
| WO-2003097657-A9 | AN ANTIMICROBIAL AGENT | UNIV GRIFFITH (AU) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004018487-A1 | CHIRAL ORGANOSILICON HYDRIDES | CHIROGEN PTY LIMITED (AU) | 2004-03-04 | — | — | WO | disclosed |
| US-6696611-B2 | Chemical methods | CHIROGEN PTY. LIMITED (AU) | 2004-02-24 | — | — | US | disclosed |
| WO-2004011473-A1 | ORGANOGERMANIUM COMPOUNDS AND METHODS FOR THEIR USE | CHIROGEN PTY LIMITED (AU) | 2004-02-05 | — | — | WO | disclosed |
| WO-2004007461-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2004-01-22 | — | — | WO | disclosed |
| US-6680401-B1 | BORON COMPOUNDS SUCH AS 4-(METHOXYMETHYL)-1,3,2-DIOXABOROLANE, USED AS COUPLERS OR CHEMICAL INTERMEDIATES FOR DRUGS, PESTICIDES OR IN COMBINATORIAL CHEMISTRY | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-01-20 | — | — | US | disclosed |
| US-20040010140-A1 | Process for preparation of bicyclic and polycyclic molecules | MONASH UNIVERSITY (AU) | 2004-01-15 | — | — | US | disclosed |
| US-20030232766-A1 | Combinatorial libraries of monosaccharides | VAST BIOSCIENCE PTY LIMITED (AU) | 2003-12-18 | — | — | US | disclosed |
| EP-1366015-A1 | BENZENE-1 2-DIOL MANNICH BASES LIGANDS POLYMERS AND METHOD OF SELECTIVE METAL IONS REMOVAL | TECHNOLOGICAL RESOURCES PTY. LTD. (AU) | 2003-12-03 | — | — | EP | disclosed |
| US-20030220520-A1 | Process for preparing organic boronic acid derivatives using diboronic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-11-27 | — | — | US | disclosed |
| WO-2003097657-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2003-11-27 | — | — | WO | disclosed |
| WO-2003095494-A1 | GENERATION OF SURFACE COATING DIVERSITY | BIO-LAYER PTY LIMITED (AU) | 2003-11-20 | — | — | WO | disclosed |
| US-20030208076-A1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | AUSTRALIAN NATIONAL UNIVERSITY, THE (AU) | 2003-11-06 | — | — | US | disclosed |
| EP-1149075-A4 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | DU PONT (US) | 2003-10-22 | — | — | EP | disclosed |
| US-20030171396-A1 | Sulfonamide compounds and uses thereof as medicines | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
| US-20030166979-A1 | Catalytic reduction using hydrogen | DAKTERNIEKS DAINIS (AU) | 2003-09-04 | — | — | US | disclosed |
| WO-2003070715-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2003-08-28 | — | — | WO | disclosed |
| EP-1334092-A1 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | Monash University (AU) | 2003-08-13 | — | — | EP | disclosed |
| US-6603004-B2 | Reacting diboron tetrahydroxide with boronic acid derivatives in presence of group 8-11 metal catalyst; one pot; no need for hydrolysis or hydrogenolysis | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-08-05 | — | — | US | disclosed |
| US-20030134849-A1 | Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-17 | — | — | US | disclosed |
| EP-1326873-A1 | COMBINATORIAL LIBRARIES OF MONOSACCHARIDES | Alchemia Pty Ltd (AU) | 2003-07-16 | — | — | EP | disclosed |
| WO-2003055919-A1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIVERSITY OF SYDNEY (AU) | 2003-07-10 | — | — | WO | disclosed |
| US-20030114638-A1 | Alkene borates and a process for covalently coupling organic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-06-19 | — | — | US | disclosed |
| US-6573274-B1 | Treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| US-6559310-B2 | Reacting a halogen aromatic derivative at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a suitable base for covalently coupling organic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-05-06 | — | — | US | disclosed |
| EP-0799220-B1 | POLYMERISABLE MONOMERS AND POLYMERS | COMMW SCIENT IND RES ORG (AU) | 2003-04-09 | — | — | EP | disclosed |
| US-20030060473-A1 | Piperazine compounds as inhibitors of MMP or TNF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-03-27 | — | — | US | disclosed |
| WO-2003018019-A2 | NEW USE OF CYCLIC COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-03-06 | — | — | WO | disclosed |
| US-6521757-B1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2003-02-18 | — | — | US | disclosed |
| US-20030032838-A1 | Substituted diboron compounds | BORON MOLECULAR PTY LIMITED (AU) | 2003-02-13 | — | — | US | disclosed |
| US-6515160-B2 | Boronic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-02-04 | — | — | US | disclosed |
| US-6512081-B1 | Synthesis of dithioester chain transfer agents and use of bis(thioacyl) disulfides or dithioesters as chain transfer agents | E.I. DUPONT NEMOURS AND COMPANY | 2003-01-28 | — | — | US | disclosed |
| EP-1056751-A4 | BORONIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2003-01-22 | — | — | EP | disclosed |
| US-6506925-B2 | Synthesis from haloalkenes or pseudo-haloalkenes | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-01-14 | — | — | US | disclosed |
| EP-0614664-B2 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-01-08 | — | — | EP | disclosed |
| EP-1090008-A4 | SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES | UNIV AUSTRALIAN (AU) | 2003-01-02 | — | — | EP | disclosed |
| US-20020193604-A1 | Aryl borates | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-12-19 | — | — | US | disclosed |
| US-6495643-B1 | RING OPENING POLYMERIZATION OF SUCH AS 6-METHYLENE-1,4-DITHIEPANE OPTIONALLY WITH METHYL METHACRYLATE; MINIMIZING SHRINKAGE; HIGH MOLECULAR WEIGHT; SUCH AS AMIDE, ESTER OR CARBONATE BACKBONE GROUPS; ADHESIVES, COMPOSITES, LENSES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2002-12-17 | — | — | US | disclosed |
| US-6495542-B1 | SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| US-6489324-B2 | TREATING STROKE, ARHTRITIS, CANCER, TISSUE ULCERATION, DECUBITIS ULCER, RESTENOSIS, PERIODONTAL DISEASE, EPIDERMOLYSIS BULLOSA, SCLERITIS, PSORIASIS, AIDS, SEPSIS, AND SEPTIC SHOCK. | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-03 | — | — | US | disclosed |
| EP-1259499-A1 | THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-27 | — | — | EP | disclosed |
| US-6469171-B1 | NON-TOXIC MODULATORS OF THE MULTIDRUG RESISTANT PHENOTYPE | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20020151743-A1 | Process for preparing organic boronic avid derivatives using diboronic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-10-17 | — | — | US | disclosed |
| US-20020133039-A1 | Chemical methods | DEAKIN UNIVERSITY (AU) | 2002-09-19 | — | — | US | disclosed |
| US-20020128270-A1 | Piperazine compounds as inhibitors of MMP or TNF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-09-12 | — | — | US | disclosed |
| WO-2002070456-A1 | BENZENE-1 2-DIOL MANNICH BASES LIGANDS POLYMERS AND METHOD OF SELECTIVE METAL IONS REMOVAL | TECHNOLOGICAL RESOURCES PTY LIMITED (AU) | 2002-09-12 | — | — | WO | disclosed |
| US-6448433-B1 | REACTING AN ORGANIC HALIDE WITH TETRAHYDROXYDIBORON; GROUP 8-11 METAL CATALYST | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2002-09-10 | — | — | US | disclosed |
| EP-0562599-B1 | Condensed thiadiazole derivative, method of its production, and use thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-09-04 | — | — | EP | disclosed |
| EP-1127060-A4 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2002-08-21 | — | — | EP | disclosed |
| EP-0986541-A4 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMW SCIENT IND RES ORG (AU) | 2002-08-14 | — | — | EP | disclosed |
| US-20020099212-A1 | For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2002-07-25 | — | — | US | disclosed |
| EP-1224190-A1 | SUBSTITUTED DIBORON COMPOUNDS | Commonwealth Scientific and Research Organisation (AU) | 2002-07-24 | — | — | EP | disclosed |
| US-6414003-B1 | ANTIULCER AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-02 | — | — | US | disclosed |
| EP-1214317-A1 | ANTIVIRAL AGENTS | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) | 2002-06-19 | — | — | EP | disclosed |
| EP-0993463-A4 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2002-06-12 | — | — | EP | disclosed |
| US-6399779-B1 | REACTING A HALOGEN AROMATIC DERIVATIVE AT A COUPLING POSITION WITH A DIBORON DERIVATIVE IN THE PRESENCE OF A GROUP 8 METAL CATALYST | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-06-04 | — | — | US | disclosed |
| EP-1019414-A4 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMW SCIENT IND RES ORG (AU) | 2002-05-29 | — | — | EP | disclosed |
| WO-2002034736-A1 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | MONASH UNIVERSITY (AU) | 2002-05-02 | — | — | WO | disclosed |
| US-20020052522-A1 | Boronic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION | 2002-05-02 | — | — | US | disclosed |
| WO-2002032915-A1 | COMBINATORIAL LIBRARIES OF MONOSACCHARIDES | ALCHEMIA PTY LTD (AU) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002028345-A2 | ALDEHYDE-RELEASING COMPOUNDS | LA TROBE UNIVERSITY (AU) | 2002-04-11 | — | — | WO | disclosed |
| US-20020032339-A1 | ARYL BORATES | BORON MOLECULAR LIMITED (AU) | 2002-03-14 | — | — | US | disclosed |
| EP-1121365-A4 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2002-03-06 | — | — | EP | disclosed |
| US-6348474-B1 | COMPOUNDS AS ANTIDIABETIC AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-02-19 | — | — | US | disclosed |
| US-6346639-B1 | Boronic compounds | THE COMMONWEALTH OF AUSTRALIA COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2002-02-12 | — | — | US | disclosed |
| US-20020016489-A1 | Alkene borates and a process for covalently coupling organic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION | 2002-02-07 | — | — | US | disclosed |
| US-6344556-B1 | THIO CONTAINING MONOMERS FOR POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-02-05 | — | — | US | disclosed |
| EP-1044194-A4 | RECEPTOR WITH AN AFFINITY FOR COMPOUNDS OF THE OXAZOLINE CLASS | UNIV MELBOURNE (AU) | 2002-01-09 | — | — | EP | disclosed |
| US-6333324-B1 | FOR THERAPY AND PROPHYLAXIS OF MATRIX METALLOPROTEINASES (MMP) OR TUMOR NECROSIS FACTOR .ALPHA. (TNF.ALPHA.), MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-12-25 | — | — | US | disclosed |
| US-6333391-B1 | FROM AMINES AND CARBOXYLIC ACIDS OR ANHYDRIDES, IN WATER; | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-12-25 | — | — | US | disclosed |
| WO-2001094348-A1 | ANTIVIRAL AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-12-13 | — | — | WO | disclosed |
| EP-1149075-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-10-31 | — | — | EP | disclosed |
| EP-1140895-A2 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-1136492-A1 | SULFONAMIDE COMPOUNDS AND USES THEREOF AS MEDICINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-09-26 | — | — | EP | disclosed |
| US-6288259-B1 | 1,3,2-DIOXABOROLANES OR OR DIOXABOROLANES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-09-11 | — | — | US | disclosed |
| EP-1127060-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001060808-A1 | THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-23 | — | — | WO | disclosed |
| EP-1121365-A1 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-08-08 | — | — | EP | disclosed |
| EP-1112250-A1 | THERAPEUTIC COMPOUNDS AND METHODS | Institute of Molecular and Cell Biology (SG) | 2001-07-04 | — | — | EP | disclosed |
| WO-2001029051-A1 | SUBSTITUTED DIBORON COMPOUNDS | COMMONWEALTH SCIENTIFIC AND RESEARCH ORGANISATION (AU) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001025179-A1 | PREPARATION OF TETRACYCLIC INTERMEDIATES | INSTITUTE OF DRUG TECHNOLOGY AUSTRALIA LIMITED (AU) | 2001-04-12 | — | — | WO | disclosed |
| EP-1090008-A1 | SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2001-04-11 | — | — | EP | disclosed |
| WO-2001019822-A1 | ANTIVIRAL AGENTS | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2001-03-22 | — | — | WO | disclosed |
| EP-0981517-A4 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | UNIV AUSTRALIAN (AU) | 2001-01-24 | — | — | EP | disclosed |
| US-6169102-B1 | ANTI-HELICOBACTER PYLORI AGENT COMPRISING AN OXAZOLIN-4-ONE DERIVATIVE USEFUL AS A THERAPEUTIC AGENT FOR GASTRIC AND DUODENAL ULCER | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| US-6162828-A | IMMUNOLOGY; ANTIINFLAMMATORY AGENTS; ANTITUMOR AGENTS; BONE DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-19 | — | — | US | disclosed |
| EP-1056751-A1 | BORONIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-12-06 | — | — | EP | disclosed |
| CN-1275984-A | Process for preparing organic boronic acid derivatives using diboronic acid | COMMW SCIENT IND RES ORG (AU) | 2000-12-06 | — | — | CN | disclosed |
| EP-1051415-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-15 | — | — | EP | disclosed |
| EP-0672678-B1 | Azapeptide derivative | FUJIREBIO KK (JP) | 2000-10-25 | — | — | EP | disclosed |
| EP-1044194-A1 | RECEPTOR WITH AN AFFINITY FOR COMPOUNDS OF THE OXAZOLINE CLASS | THE UNIVERSITY OF MELBOURNE (AU) | 2000-10-18 | — | — | EP | disclosed |
| EP-1000108-A4 | AQUEOUS POLYIMIDE PROCESS | COMMW SCIENT IND RES ORG (AU) | 2000-10-11 | — | — | EP | disclosed |
| EP-1019414-A1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-07-19 | — | — | EP | disclosed |
| WO-2000040576-A2 | THIOPYRAN COMPOUNDS AS INHIBITORS OF MMP | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000027853-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-05-18 | — | — | WO | disclosed |
| EP-1000108-A1 | AQUEOUS POLYIMIDE PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-05-17 | — | — | EP | disclosed |
| EP-0995742-A1 | SULFONAMIDE COMPOUNDS AND MEDICINAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-26 | — | — | EP | disclosed |
| WO-2000021966-A1 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-04-20 | — | — | WO | disclosed |
| EP-0993463-A1 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-04-19 | — | — | EP | disclosed |
| US-6043361-A | ALLYLIC COMPOUND CONTAINING CYCLIZED SULFUR CONTAINING RINGS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-03-28 | — | — | US | disclosed |
| EP-0986541-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-03-22 | — | — | EP | disclosed |
| WO-2000014063-A1 | THERAPEUTIC COMPOUNDS AND METHODS | INSTITUTE OF MOLECULAR & CELL BIOLOGY (SG) | 2000-03-16 | — | — | WO | disclosed |
| EP-0981517-A1 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998050365-A9 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | UNIV AUSTRALIAN (AU) | 2000-02-03 | — | — | WO | disclosed |
| EP-0706532-B1 | Peptides having endothelin antagonictic activity,their preparation and pharmaceutical compositions | FUJISAWA PHARMACEUTICAL CO (JP) | 2000-02-02 | — | — | EP | disclosed |
| WO-1999067250-A1 | SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1999-12-29 | — | — | WO | disclosed |
| EP-0948489-A1 | PIPERAZINE COMPOUNDS AS INHIBITORS OF MMP OR TNF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
| US-5965538-A | FOR TREATING NERVOUS INFLAMMATION OF RESPIRATORY SYSTEMS, ASTHMA, BRONCHOSPASM | FUJIREBIO INC. (JP) | 1999-10-12 | — | — | US | disclosed |
| WO-1999037637-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-07-29 | — | — | WO | disclosed |
| WO-1999033845-A1 | BORONIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-07-08 | — | — | WO | disclosed |
| EP-0923577-A2 | OXAZOLONE DERIVATIVES AND THEIR USE AS ANTI-HELICOBACTER PYLORI AGENT | Takeda Chemical Industries, Ltd. (JP) | 1999-06-23 | — | — | EP | disclosed |
| WO-1999024411-A1 | RECEPTOR WITH AN AFFINITY FOR COMPOUNDS OF THE OXAZOLINE CLASS | THE UNIVERSITY OF MELBOURNE (AU) | 1999-05-20 | — | — | WO | disclosed |
| US-5889009-A | ADMINISTERING 1,7-DISUBSTITUTED-4-OX-3-(QUINOLINECARBOXYLIC ACID OR NAPHTHYRIDINECARBOXYLIC ACID) | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
| US-5888972-A | ENDOTHELIN ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
| WO-1999012940-A1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-03-18 | — | — | WO | disclosed |
| WO-1999006470-A1 | AQUEOUS POLYIMIDE PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-11 | — | — | WO | disclosed |
| WO-1999005099-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-04 | — | — | WO | disclosed |
| US-5856556-A | Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics | SANKYO COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | disclosed |
| WO-1998058935-A1 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-12-30 | — | — | WO | disclosed |
| WO-1998051687-A1 | PIPERIDINO DERIVATIVES WHICH PROMOTE GROWTH HORMONE RELEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-19 | — | — | WO | disclosed |
| US-5837687-A | BRONCHODILATORS, ANTIHISTAMINES AND ANTIINFLAMMATORY AGENTS; ASTHMA; ANTAGONIST OF NEUROKININ RECEPTORS | FUJIREBIO INC. (JP) | 1998-11-17 | — | — | US | disclosed |
| WO-1998050365-A1 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998045265-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-10-15 | — | — | WO | disclosed |
| EP-0614664-B1 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-09-16 | — | — | EP | disclosed |
| EP-0545376-B1 | Guanidino thiazoles and their use as H2-receptor antagonist | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-09-09 | — | — | EP | disclosed |
| WO-1998027069-A1 | PIPERAZINE COMPOUNDS AS INHIBITORS OF MMP OR TNF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-25 | — | — | WO | disclosed |
| WO-1998024785-A1 | INDOLE-UREA DERIVATIVES WITH 5-HT ANTAGONIST PROPERTIES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-11 | — | — | WO | disclosed |
| US-5756765-A | BACTERICIDES AND ANTIBIOTICS | CHONG KUN DANG CORP. (KR) | 1998-05-26 | — | — | US | disclosed |
| EP-0799220-A4 | POLYMERISABLE MONOMERS AND POLYMERS | COMMW SCIENT IND RES ORG (AU) | 1998-04-15 | — | — | EP | disclosed |
| EP-0457195-B1 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-04-15 | — | — | EP | disclosed |
| US-5739130-A | TREATING SYSTEMIC LUPUS ERYTHEMATOSIS, MELANOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-04-14 | — | — | US | disclosed |
| EP-0820464-A2 | CYSTEINE PROTEASE INHIBITOR | Takeda Chemical Industries, Ltd. (JP) | 1998-01-28 | — | — | EP | disclosed |
| WO-1997049703-A2 | OXAZOLONE DERIVATIVES AND THEIR USE AS ANTI-HELICOBACTER PYLORI AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-12-31 | — | — | WO | disclosed |
| US-5703081-A | CELL ADHESION INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-12-30 | — | — | US | disclosed |
| WO-1997041128-A1 | 3-PYRAZOLIOMETHYLCEPHEM COMPOUNDS AS ANTIMICROBIAL AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-11-06 | — | — | WO | disclosed |
| EP-0799220-A1 | POLYMERISABLE MONOMERS AND POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1997-10-08 | — | — | EP | disclosed |
| EP-0793673-A1 | ALPHA-KETOAMIDE DERIVATIVES AS CATHEPSIN L INHIBITOR | Takeda Chemical Industries, Ltd. (JP) | 1997-09-10 | — | — | EP | disclosed |
| US-5656604-A | HYPOTENSIVE AGENT; ENDOTHELIN ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-12 | — | — | US | disclosed |
| EP-0783489-A1 | ALDEHYDE DERIVATIVES AS UPSTEINE PROTEASE INHIBITORS | Takeda Chemical Industries, Ltd. (JP) | 1997-07-16 | — | — | EP | disclosed |
| US-5641770-A | THIENAMYCINS ANTIBIOTICS | CHONG KUN DANG CORP. (KR) | 1997-06-24 | — | — | US | disclosed |
| US-5624931-A | Pyrazole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-29 | — | — | US | disclosed |
| US-5616556-A | USING A CYCLIC PEPTIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0336230-B1 | Cyclic peptide antagonists of Substance P and Substance K | FUJISAWA PHARMACEUTICAL CO (JP) | 1997-02-12 | — | — | EP | disclosed |
| US-5594132-A | ANTIBIOTIC | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-01-14 | — | — | US | disclosed |
| US-5583135-A | TREATING SYSTEMIC LUPUS ERYTHEMATOSIS OR MELANOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-10 | — | — | US | disclosed |
| US-5574016-A | Peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-12 | — | — | US | disclosed |
| WO-1996030395-A2 | CYSTEINE PROTEASE INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-10-03 | — | — | WO | disclosed |
| EP-0731107-A1 | Production of aldehyde derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-09-11 | — | — | EP | disclosed |
| EP-0513675-B1 | New peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-5550138-A | PREVENT BONE RESORPTION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-08-27 | — | — | US | disclosed |
| US-5532258-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| WO-1996019471-A1 | POLYMERISABLE MONOMERS AND POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1996-06-27 | — | — | WO | disclosed |
| WO-1996016079-A2 | ALPHA-KETOAMIDE DERIVATIVES AS CATHEPSIN L INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD (JP) | 1996-05-30 | — | — | WO | disclosed |
| US-5519024-A | CELL ADHESION INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-05-21 | — | — | US | disclosed |
| EP-0333174-B1 | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-05-08 | — | — | EP | disclosed |
| US-5512588-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-30 | — | — | US | disclosed |
| EP-0706532-A1 | NEW COMPOUND AND ITS PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-17 | — | — | EP | disclosed |
| WO-1996010014-A1 | ALDEHYDE DERIVATIVES AS UPSTEINE PROTEASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-04-04 | — | — | WO | disclosed |
| EP-0330108-B1 | 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds | FUJISAWA PHARMACEUTICAL CO (JP) | 1995-12-27 | — | — | EP | disclosed |
| US-5478827-A | Inhibits Interleukin-1 and tumor necrosis factor production | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-12-26 | — | — | US | disclosed |
| EP-0687473-A1 | OPTICAL ISOMERIZATION INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-12-20 | — | — | EP | disclosed |
| WO-1995031202-A1 | CAGE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTIVIRAL AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1995-11-23 | — | — | WO | disclosed |
| US-5461048-A | Tricyclic compounds having cholecystokinin antagonist activity | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-10-24 | — | — | US | disclosed |
| EP-0674640-A1 | 2-(2-SUBSTITUTED PYRROLIDIN-4-YL)THIO-CARBAPENEM DERIVATIVES | CHONG KUN DANG CORP (KR) | 1995-10-04 | — | — | EP | disclosed |
| EP-0672678-A1 | Azapeptide derivative | FUJIREBIO Inc. (JP) | 1995-09-20 | — | — | EP | disclosed |
| EP-0669334-A1 | TRICYCLIC COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-08-30 | — | — | EP | disclosed |
| WO-1995022330-A1 | ANTIVIRAL AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1995-08-24 | — | — | WO | disclosed |
| US-5436140-A | Cyclic peptides as antagonist, analgesics or antihistamines | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| US-5430022-A | Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-04 | — | — | US | disclosed |
| EP-0658162-A1 | CARBAPENEM DERIVATIVES AND PROCESSES FOR PREPARING THE SAME | DONG-A PHARM. CO., LTD. (KR) | 1995-06-21 | — | — | EP | disclosed |
| US-5420122-A | MICROBIOCIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-05-30 | — | — | US | disclosed |
| US-5401737-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-03-28 | — | — | US | disclosed |
| WO-1995000537-A1 | NEW COMPOUND AND ITS PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-01-05 | — | — | WO | disclosed |
| EP-0625983-A1 | HETEROTRICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-30 | — | — | EP | disclosed |
| US-5356897-A | Inhibit the production of Interleukin-1 and tumor necrosis factor; administering for treatment of chronic inflammatory diseases, autoimmune diseases and sepsis-induced organ injury | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-18 | — | — | US | disclosed |
| WO-1994020126-A1 | USE OF PEPTIDES FOR THE MANUFACTURE OF A MEDICAMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-15 | — | — | WO | disclosed |
| EP-0614664-A1 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-14 | — | — | EP | disclosed |
| WO-1994014811-A1 | 2-(2-SUBSTITUTED PYRROLIDIN-4-YL)THIO-CARBAPENEM DERIVATIVES | CHONG KUN DANG CORP. (KR) | 1994-07-07 | — | — | WO | disclosed |
| US-5322842-A | Tricyclic benzodiazepine derivates, their preparation, and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-21 | — | — | US | disclosed |
| EP-0601184-A1 | FUSED PYRIDAZINE COMPOUND AND PHARMACEUTICAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0598906-A1 | FURYLTHIAZOLE AND THEIR USE AS H 2?-RECEPTOR ANTAGONISM AND ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-01 | — | — | EP | disclosed |
| US-5308857-A | Antiulcer agents | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-05-03 | — | — | US | disclosed |
| EP-0237735-B1 | 3,7-Disubstituted-3-cephem compounds and process for production of the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-03-30 | — | — | EP | disclosed |
| WO-1994005667-A1 | CARBAPENEM DERIVATIVES AND PROCESSES FOR PREPARING THE SAME | DONG-A PHARMACEUTICAL CO., LTD. (KR) | 1994-03-17 | — | — | WO | disclosed |
| EP-0223246-B1 | New cephem compounds and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-03-02 | — | — | EP | disclosed |
| US-5284828-A | Hypotensive agents | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 1994-02-08 | — | — | US | disclosed |
| EP-0360079-B1 | Tricyclic compounds, processes for their preparation and pharmaceutical compositions comprising them | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-02-02 | — | — | EP | disclosed |
| EP-0575614-A1 | THIAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-12-29 | — | — | EP | disclosed |
| WO-1993024485-A1 | OXAZOLE DERIVATIVES AND THEIR USE AS ANTIULCER AGENTS AND H2-RECEPTOR ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-12-09 | — | — | WO | disclosed |
| EP-0307804-B1 | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1993-11-18 | — | — | EP | disclosed |
| US-5252731-A | Antibiotics | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-10-12 | — | — | US | disclosed |
| EP-0562599-A1 | Condensed thiadiazole derivative, method of its production, and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1993-09-29 | — | — | EP | disclosed |
| US-5248679-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-28 | — | — | US | disclosed |
| WO-1993015083-A1 | HETEROTRICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-05 | — | — | WO | disclosed |
| EP-0280771-B1 | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| EP-0544909-A1 | TRICYCLIC BENZODIAZEPINE DERIVATES THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-09 | — | — | EP | disclosed |
| EP-0545376-A1 | Guanidino thiazoles and their use as H2-receptor antagonist | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-09 | — | — | EP | disclosed |
| US-5217952-A | Analgesics, antihistamine | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-08 | — | — | US | disclosed |
| EP-0239853-B1 | 3,4-DISUBSTITUTED-2-AZETIDINONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-05-19 | — | — | EP | disclosed |
| EP-0272456-B1 | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-31 | — | — | EP | disclosed |
| EP-0244637-B1 | STARTING COMPOUNDS FOR 7-ACYLAMINO-3-VINYLCEPHALOSPORANIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | disclosed |
| EP-0531901-A2 | Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-5194432-A | Drugs for treatment of infectious diseases; microbiocides | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-16 | — | — | US | disclosed |
| WO-1993003028-A1 | FURYLTHIAZOLE AND THEIR USE AS H2-RECEPTOR ANTAGONISM AND ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-18 | — | — | WO | disclosed |
| US-5187156-A | D-Tryptophan- and Phenylalanine-containing tripeptides as tachykinin antagonists; asthma | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-16 | — | — | US | disclosed |
| US-5187160-A | CEPHEM COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-16 | — | — | US | disclosed |
| EP-0272455-B1 | 3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-10 | — | — | EP | disclosed |
| EP-0513675-A1 | New peptide compound and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| US-5155101-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1992-10-13 | — | — | US | disclosed |
| WO-1992016526-A1 | THIAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-10-01 | — | — | WO | disclosed |
| EP-0498069-A2 | New use of peptide derivative | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-08-12 | — | — | EP | disclosed |
| US-5138064-A | Chemical intermediate for penicillin derivative | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1992-08-11 | — | — | US | disclosed |
| WO-1992012154-A1 | IMIDAZOTRIAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-07-23 | — | — | WO | disclosed |
| US-5110921-A | Bactericides | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-05-05 | — | — | US | disclosed |
| US-5102997-A | Antibiotics | SANKYO COMPANY LIMITED (JP) | 1992-04-07 | — | — | US | disclosed |
| WO-1992003438-A1 | TRICYCLIC BENZODIAZEPINE DERIVATES THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-03-05 | — | — | WO | disclosed |
| WO-1992002513-A1 | HETEROCYCLIC COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-02-20 | — | — | WO | disclosed |
| WO-1992002521-A1 | 1-AZABICYCLO[3.2.0]HEPT-2-ENE-2-CARBOXYLIC ACID COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-02-20 | — | — | WO | disclosed |
| US-5081237-A | Chemical intermediates for bactericides | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1992-01-14 | — | — | US | disclosed |
| US-5075437-A | 3,4-DISUBSTITUTED-2-AZETIDINONE DERIVATIVES AND PROCESSES FOR PREPARATION USING TIN ENOLATES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-12-24 | — | — | US | disclosed |
| EP-0457195-A2 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-11-21 | — | — | EP | disclosed |
| US-5061804-A | 3-thiopyrrolidine as chemical intermediates | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-10-29 | — | — | US | disclosed |
| US-5026695-A | Gram negative-gram positive microbiocides, oral adminis tration | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-06-25 | — | — | US | disclosed |
| EP-0417751-A2 | New thiazole derivatives, processes for the preparation thereof and pharmaceutical compositon comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-03-20 | — | — | EP | disclosed |
| US-4981847-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-01-01 | — | — | US | disclosed |
| US-4963543-A | BACTERICIDES, TREATING INFECTIOUS DISEASES; THIENAMYCINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-10-16 | — | — | US | disclosed |
| US-4960889-A | CEPHALOSPORIN INTERMEDIATES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-10-02 | — | — | US | disclosed |
| US-4960766-A | SUBSTITUTED 2-PYRAZOLIOMETHYL GROUP AND A 7-(AMINOTHIAZOLYL) (ALKOXYIMINO)-ACETAMIDO GROUP CEPHALOSPORIN DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-10-02 | — | — | US | disclosed |
| EP-0386689-A1 | New cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-09-12 | — | — | EP | disclosed |
| US-4952578-A | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| US-4931555-A | CEPHALOSPORINS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-06-05 | — | — | US | disclosed |
| EP-0166389-B1 | NEW TETRACYCLO COMPOUNDS, A PROCESS FOR THEIR PRODUCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-05-23 | — | — | EP | disclosed |
| US-4925948-A | CEPHALOSPORIN ANTIBIOTIC CHEMICAL INTERMEDIATES | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-05-15 | — | — | US | disclosed |
| US-4923857-A | CARBAPENICILLINS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-05-08 | — | — | US | disclosed |
| US-4921852-A | CARBAPENICILLINS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-05-01 | — | — | US | disclosed |
| US-4920129-A | Anti-ulcerative imidazopyridine compounds | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-04-24 | — | — | US | disclosed |
| EP-0360079-A1 | Tricyclic compounds, processes for their preparation and pharmaceutical compositions comprising them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-03-28 | — | — | EP | disclosed |
| EP-0355612-A2 | Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
| US-4904652-A | 7-acylamino-3-substituted cephalosporanic acid derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-02-27 | — | — | US | disclosed |
| EP-0336230-A2 | Cyclic peptide antagonists of Substance P and Substance K | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-10-11 | — | — | EP | disclosed |
| EP-0335390-A2 | Novel cephalosporin compounds | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-10-04 | — | — | EP | disclosed |
| EP-0333174-A2 | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-20 | — | — | EP | disclosed |
| US-4868174-A | CEPHALOSPORIN ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0330108-A1 | 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-08-30 | — | — | EP | disclosed |
| US-4861774-A | Method of treating tumors using tetracyclo compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-08-29 | — | — | US | disclosed |
| EP-0055465-B1 | 7-ACYLAMINOCEPHALOSPORANIC ACID DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-08-23 | — | — | EP | disclosed |
| US-4831041-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-05-16 | — | — | US | disclosed |
| US-4822787-A | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid compounds and antimicrobial activity thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-04-18 | — | — | US | disclosed |
| EP-0308917-A2 | Imidazopyridine compound, a process for preparation thereof and pharmaceutical compositions comprising them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-03-29 | — | — | EP | disclosed |
| EP-0105459-B1 | SYN-ISOMER OF 7-SUBSTITUTED-3-VINYL-3-CEPHEM COMPOUNDS, PROCESSES FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-03-22 | — | — | EP | disclosed |
| EP-0307804-A2 | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-03-22 | — | — | EP | disclosed |
| EP-0280771-A1 | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-09-07 | — | — | EP | disclosed |
| EP-0272456-A1 | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-06-29 | — | — | EP | disclosed |
| EP-0272455-A1 | 3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-06-29 | — | — | EP | disclosed |
| EP-0268989-A1 | Imidazopyridine compounds and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-06-01 | — | — | EP | disclosed |
| US-4743555-A | TETRACYCLO COMPOUND, ANTITUMOR, ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-05-10 | — | — | US | disclosed |
| EP-0107850-B1 | AMINOGLYCOSIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-04-06 | — | — | EP | disclosed |
| US-4731443-A | 7-acylamino-3-vinylcephalosporanic acid derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-03-15 | — | — | US | disclosed |
| EP-0090366-B1 | 1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-11-25 | — | — | EP | disclosed |
| EP-0244637-A1 | Starting compounds for 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-11-11 | — | — | EP | disclosed |
| US-4705851-A | Process for the preparation of 3-phosphoniummethyl-3-cephem compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-11-10 | — | — | US | disclosed |
| EP-0244195-A1 | 2-Vinylpenams and process | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (GB) | 1987-11-04 | — | — | EP | disclosed |
| EP-0102239-B1 | AZETIDINONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATES IN THE PREPARATION OF CARBAPENEM ANTIBIOTICS | SANKYO COMPANY LIMITED (JP) | 1987-10-14 | — | — | EP | disclosed |
| EP-0239853-A1 | 3,4-Disubstituted-2-azetidinone derivatives and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-10-07 | — | — | EP | disclosed |
| EP-0237735-A2 | 3,7-Disubstituted-3-cephem compounds and process for production of the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-09-23 | — | — | EP | disclosed |
| EP-0132987-B1 | IMPROVEMENTS IN OR RELATING TO DEESTERIFICATION TO ACIDS | ELI LILLY AND COMPANY (US) | 1987-09-16 | — | — | EP | disclosed |
| EP-0223246-A2 | New cephem compounds and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-05-27 | — | — | EP | disclosed |
| EP-0074645-B1 | NEW CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL ANTIBACTERIAL COMPOSITION CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-04-08 | — | — | EP | disclosed |
| US-4656160-A | VIRICIDES; HERPES VIRUS; TOBRAMYCINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-04-07 | — | — | US | disclosed |
| EP-0030630-B1 | 7-ACYLAMINO-3-VINYLCEPHALOSPORANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM; THEIR STARTING COMPOUNDS AND THEIR PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-04-01 | — | — | EP | disclosed |
| EP-0214462-A2 | 3,7-Disubstituted-3-cephem compounds and processes for production of the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-03-18 | — | — | EP | disclosed |
| US-4645765-A | MICROBIOCIDES, ANTITUMOR AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-02-24 | — | — | US | disclosed |
| US-4643990-A | ANTICOAGULANTS, IMMUNE-COMPLEX OR AUTOIMMUNE DISEASES, RHEUMATIC, LUPUS, NEPHRITIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-02-17 | — | — | US | disclosed |
| US-4640915-A | MICROBIOCIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-02-03 | — | — | US | disclosed |
| EP-0085255-B1 | N-ACYL PEPTIDE, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSTIONS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-09-10 | — | — | EP | disclosed |
| EP-0046964-B1 | NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-08-20 | — | — | EP | disclosed |
| US-4596829-A | Pharmaceuticals | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-06-24 | — | — | US | disclosed |
| EP-0183241-A2 | New aminoglycoside derivatives processes for the preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-06-04 | — | — | EP | disclosed |
| US-4591590-A | ANTIALLERGINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-27 | — | — | US | disclosed |
| US-4585860-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-04-29 | — | — | US | disclosed |
| US-4576753-A | MICROBIOCIDES, ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-03-18 | — | — | US | disclosed |
| EP-0166389-A1 | New tetracyclo compounds, a process for their production and a pharmaceutical composition containing the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | disclosed |
| US-4559334-A | MICROBIOCIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-12-17 | — | — | US | disclosed |
| EP-0160391-A1 | Carbapenem derivatives and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1985-11-06 | — | — | EP | disclosed |
| US-4550102-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 1985-10-29 | — | — | US | disclosed |
| EP-0156118-A1 | New starting compounds for the preparation of cephem compounds and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-10-02 | — | — | EP | disclosed |
| EP-0029557-B1 | 7-ACYLAMINO-3-SUBSTITUTED CEPHALOSPORANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-03-13 | — | — | EP | disclosed |
| EP-0132987-A1 | Improvements in or relating to deesterification to acids | ELI LILLY AND COMPANY (US) | 1985-02-13 | — | — | EP | disclosed |
| US-4497738-A | Analogous compounds of cephalosporins, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-02-05 | — | — | US | disclosed |
| US-4493831-A | ANTIBIOTICS, VIRICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-01-15 | — | — | US | disclosed |
| US-4487927-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-12-11 | — | — | US | disclosed |
| EP-0123024-A2 | 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-31 | — | — | EP | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |
| US-4473566-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-25 | — | — | US | disclosed |
| US-4472300-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4472309-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4462999-A | CEPHALOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-31 | — | — | US | disclosed |
| EP-0113226-A1 | Benzhydrylpiperazine derivatives, processes for the preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-11 | — | — | EP | disclosed |
| EP-0017138-B1 | ANALOGOUS COMPOUNDS OF CEPHALOSPORINS, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-04 | — | — | EP | disclosed |
| EP-0108977-A2 | Starting compounds for preparing 7-acylamino-3-substituted cephalosporanic acid derivatives and process for their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-05-23 | — | — | EP | disclosed |
| EP-0107850-A1 | Aminoglycoside derivatives, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-05-09 | — | — | EP | disclosed |
| EP-0105459-A2 | Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-04-18 | — | — | EP | disclosed |
| US-4438113-A | 7-Acylaminocephalosporanic acid derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-03-20 | — | — | US | disclosed |
| EP-0102239-A1 | Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics | SANKYO COMPANY LIMITED (JP) | 1984-03-07 | — | — | EP | disclosed |
| US-4435321-A | BACTERICIDES AND INTERMEDIATES FOR 2- OR 3-CEPHEMS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-03-06 | — | — | US | disclosed |
| US-4423213-A | ANTIBIOTIC | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-12-27 | — | — | US | disclosed |
| US-4411900-A | ANTIALLERGENS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-25 | — | — | US | disclosed |
| US-4410458-A | GROUP 5B OR 6B METAL COMPOUND OXIDATION CATALYST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4409214-A | Including cefixime; antibiotics | FUJISAWA PHARMACEUTICAL, CO., LTD. (JP) | 1983-10-11 | — | — | US | disclosed |
| US-4409215-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-11 | — | — | US | disclosed |
| EP-0090366-A1 | 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-05 | — | — | EP | disclosed |
| US-4407798-A | CEPHALOSPORINS; BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-04 | — | — | US | disclosed |
| EP-0085255-A2 | N-acyl peptide, processes for their preparation and pharmaceutical compostions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-08-10 | — | — | EP | disclosed |
| US-4397784-A | AMINO ACID DERIVATIVE ANTIBIOTICS | ABBOTT LABORATORIES (US) | 1983-08-09 | — | — | US | disclosed |
| EP-0010667-B1 | CEPHAM COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION THEREOF AND OF KNOWN CEPHEM COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-07-20 | — | — | EP | disclosed |
| US-4385176-A | RING EXPANSION USING A LEWIS ACID | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-05-24 | — | — | US | disclosed |
| EP-0074645-A2 | New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-03-23 | — | — | EP | disclosed |
| EP-0070575-A2 | New starting compounds for preparing analogous compounds of cephalosporins and processes for their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-26 | — | — | EP | disclosed |
| US-4370332-A | MUSCLE RELAXANTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| US-4363807-A | BACTERICIDES AND USEFUL ANTIBIOTIC INTERMEDIATES | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1982-12-14 | — | — | US | disclosed |
| US-4347355-A | Inhibitors of transpeptidase | ABBOTT LABORATORIES (US) | 1982-08-31 | — | — | US | disclosed |
| US-4339449-A | Analogous compounds of cephalosporins, and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1982-07-13 | — | — | US | disclosed |
| EP-0055465-A2 | 7-Acylaminocephalosporanic acid derivatives and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-07-07 | — | — | EP | disclosed |
| WO-1982001875-A1 | INHIBITORS OF TRANSPEPTIDASE | ABBOTT LAB (US) | 1982-06-10 | — | — | WO | disclosed |
| US-4334014-A | CONTAINING A CEPHALOSPORIN | FUJI PHOTO FILM CO., LTD. (JP) | 1982-06-08 | — | — | US | disclosed |
| EP-0046964-A2 | New cephem compounds and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-03-10 | — | — | EP | disclosed |
| US-4308380-A | 2-Lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-29 | — | — | US | disclosed |
| US-4304718-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-08 | — | — | US | disclosed |
| US-4292320-A | SMOOTH MUSCLE RELAXANTS | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1981-09-29 | — | — | US | disclosed |
| EP-0032058-A1 | Thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-07-15 | — | — | EP | disclosed |
| EP-0030630-A2 | 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-06-24 | — | — | EP | disclosed |
| EP-0029557-A2 | 7-Acylamino-3-substituted cephalosporanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-06-03 | — | — | EP | disclosed |
| US-4267340-A | BACTERICIDES; SYNTHESIS OF PENICILLINS AND CEPHALOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-12 | — | — | US | disclosed |
| US-4264498-A | REACTED WITH AN ACID, ITS ACID HALIDE, OR ANHYDRIDE IN THE PRESENCE OF BORON TRIHALIDE AND AN ORGANIC BASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
| US-4254117-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
| US-4246405-A | Method for preparation of β-lactam compound | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1981-01-20 | — | — | US | disclosed |
| US-4242507-A | Sulfonic acid esters | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-12-30 | — | — | US | disclosed |
| EP-0017138-A2 | Analogous compounds of cephalosporins, processes for their preparation, and pharmaceutical composition containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-10-15 | — | — | EP | disclosed |
| US-4207234-A | 4-Unsubstituted azetidinone derivatives and process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-06-10 | — | — | US | disclosed |
| US-4203897-A | Penam derivatives | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1980-05-20 | — | — | US | disclosed |
| EP-0010667-A1 | Cepham compounds, pharmaceutical compositions containing them and processes for the preparation thereof and of known cephem compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-05-14 | — | — | EP | disclosed |
| US-4181800-A | ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-4169150-A | MUSCLE RELAXANTS, HYPNOSIS, ANTICONVULSANTS, SEDATIVES | TEIJIN LIMITED (JP) | 1979-09-25 | — | — | US | disclosed |
| US-4143166-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-03-06 | — | — | US | disclosed |
| US-4138553-A | 3-Methylene cephalosporanic acid derivatives and process for preparation thereof | TEIJIN LIMITED (JP) | 1979-02-06 | — | — | US | disclosed |
| US-4113940-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1978-09-12 | — | — | US | disclosed |
| US-4092474-A | Cephalosporins having a metaloxy group in 3-substituent | SHIONOGI & CO., LTD. (JA) | 1978-05-30 | — | — | US | disclosed |
| US-4091210-A | Preparation of 3-alkyl-3-cephem-4-carboxylic acid compounds from dithio isopropenyl azetidine carboxylic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1978-05-23 | — | — | US | disclosed |
| US-4084049-A | CEPHALOSPORIN ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1978-04-11 | — | — | US | disclosed |
| US-4051126-A | HALOGENATION, ALKOXYLATION | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1977-09-27 | — | — | US | disclosed |
| US-4036847-A | ANTIBACTERIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-07-19 | — | — | US | disclosed |
| US-4009159-A | PENICILLINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-02-22 | — | — | US | disclosed |
| US-3993646-A | Process for the ring expansion of penicillins to cephalosporin compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-11-23 | — | — | US | disclosed |
| US-3984397-A | CYCLIZATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-10-05 | — | — | US | disclosed |
| US-3954732-A | BACTERICIDAL PENICILLINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-05-04 | — | — | US | disclosed |
| US-3954732-A | BACTERICIDAL PENICILLINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-05-04 | — | — | US | disclosed |